@prefix rr:    <http://www.w3.org/ns/r2rml#> .
@prefix ont:   <http://ontologies.vub.be/oecd#> .
@prefix rdf:   <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd:   <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs:  <http://www.w3.org/2000/01/rdf-schema#> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/13>
        a                          ont:Test ;
        ont:additional_info        "test substance: hc red n° 3" ;
        ont:clinical_observations  "body weights and survival differed little between treated and control groups." ;
        ont:composition            "test substance in a hair dye formulation (formula 7601)" ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20red%20n°%203> ;
        ont:concentration          "0.3" ;
        ont:gross_pathology        "differences between treated and control groups in absolute and relative liver and kidneys weights were not considered to be indicative of toxicological effects. chronic\ninflammation of the skin was observed in the control and treated mice. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "differences between treated and control groups in haematological and urinary values were not considered to be indicative of toxicological effects." ;
        ont:histopathology         "microscopic examinations of the skin revealed occasional hyperplasia, necrosis, ulceration and other lesions not significantly increased by dye treatment." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "mouse/ eppley swiss" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "differences between treated and control groups in haematological and urinary values were not considered to be indicative of toxicological effects." .

<http://toxin.vub.be/resource/dossier/β-arbutin>
        a              ont:Report ;
        rdfs:label     "β-arbutin" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/30> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/http%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_169.pdf> .

<http://toxin.vub.be/resource/compound/phenylene%20bis-diphenyltriazine>
        a               ont:Compound ;
        rdfs:label      "phenylene bis-diphenyltriazine" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/phenylene%20bis-diphenyltriazine> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/140>
        a                    ont:Test ;
        ont:compound         <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:gross_pathology  "pathology results were evaluated by 3 laboratories. in the nasal cavity there was a significant increase in the incidence and severity of goblet cell proliferation in males and females in the high dose group. the incidence of focal macrophage accumulation and interstitial inflammation of the lung was significantly increased in males and females in the high dose group. at this concentration, approximately 40% of the test atmosphere was expected to be a liquid aerosol which may be impacting the response in the lung. one laboratory reported a significantly increased incidence of hepatocellular hypertrophy in female in the high dose group whereas histopathological changes in the liver were not reported by the 2 others." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:species_strain   "rat" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/84>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol" ;
        ont:composition      "hair dye formulation containing p-aminophenol mixed with 6% hydrogen peroxide" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:concentration    "0.04, 0.2, 1.0" ;
        ont:conclusion       "no compound-related findings were observed. scattered variations in clinical pathology parameters were observed, but none were considered to be of toxicological significance" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rabbit" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/119>
        a                          ont:Test ;
        ont:additional_info        "test substance:OPP" ;
        ont:chemical_batch_nr      "MM09157" ;
        ont:clinical_observations  "treatment did not affect survival and body weight. no skin neoplasms occurred, however non-neoplastic lesions (ulcer, active chronic inflammation, hyperkeratosis and acanthosis) were observed at the application site. " ;
        ont:composition            "test substance dissolved in 0.1 ml acetone" ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion             "after initiation with DMBA, which was also part of the study, OPP was revealed not to be a promoter" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "systemically, slightly increased incidences of dilatation of the kidney tubules compared to acetone controls were observed in OPP treated animals. in males, a greater incidence of focal necrosis of the liver (of mild degree) was observed. after initiation with DMBA, which was also part of the study, OPP was revealed not to be a promoter." ;
        ont:purity                 "99" ;
        ont:species_strain         "mouse/Swiss CD-1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/63>
        a                           ont:Test ;
        ont:additional_info         "test substance: sodium perborate tetrahydrate" ;
        ont:blood_serum_biomarkers  "there were no statistically significant differences compared to controls in blood parameters (all relevant parameters investigated, figures included in the report)" ;
        ont:clinical_observations   "there were no statistically significant differences compared to controls in growth, organ/body weight ratios (liver, kidney). during the application of the 10 % solution to the abraded skin, some animals showed mild irritative effects. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/sodium%20perborate%20%28tetrahydrate%29> ;
        ont:concentration           "liquid" ;
        ont:gross_pathology         "there were no statistically significant differences compared to controls in  gross pathology. there were no statistically significant differences compared to controls in organ/body weight ratios (liver, kidney)." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "there were no statistically significant differences compared to controls in blood parameters (all relevant parameters investigated, figures included in the report)" ;
        ont:histopathology          "there were no statistically significant differences compared to controls in histopathology (organs required in current guidelines investigated)" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:pH_adjustment           "2.5" ;
        ont:species_strain          "rabbits/new zealand white" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/42>
        a                          ont:Test ;
        ont:clinical_observations  "all of 5 treated animals showed reduced amplitude of the evoked compound muscle action potential (cmap), 4 animals showed signs of a reduced muscle tone. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/21>
        a                          ont:Test ;
        ont:additional_info        "test substance: cetrimonium chloride" ;
        ont:clinical_observations  "slight to moderate erythema was observed in all treated rabbits between days 4 and 8, but disappeared in 4 rabbits by day 17. very slight to slight oedema was observed between days 6 and 12 in 4 rabbits and subsided by day 17. two rabbits had intermittent slight oedema during week 4, and one rabbit developed oedema on day 20. no evidence of desquamation or leather-like skin was present in these animals. in the other rabbits, slight atonia occurred up to week 4 in 3 animals. slight skin fissuring was observed in most of the rabbits but typically disappeared by the end of the study. there were no treatment-related effects on body weight." ;
        ont:compound               <http://toxin.vub.be/resource/compound/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride> ;
        ont:conclusion             "the us national toxicology programme report concluded that the toxic response only consists of skin irritation, and proposed a noael value of 10 mg/kg bw/day for systemic effects." ;
        ont:description_pod        "noael mg/kg bw/d" ;
        ont:gross_pathology        "there were no treatment-related effects on organ weight and gross necropsy findings" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "there were no treatment-related effects on haematology" ;
        ont:histopathology         "there were no treatment-related effects in histopathology, except for treated areas of the skin that showed mild to marked acanthosis with active mitosis, hyperkeratosis, and partial to extensive necrosis of the epidermis and hair follicles, partly with encrustation and exudate. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "2 control group animals died during the study" ;
        ont:point_of_departure     "10" ;
        ont:species_strain         "rabbit/new zealand albino" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/compound/vitamin%20a>
        a               ont:Compound ;
        rdfs:label      "vitamin a" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/vitamin%20a> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/92>
        a                            ont:Test ;
        ont:blood_serum_biomarkers   "nmp had no effect on clinical chemistry parameters in males or females, at any concentration" ;
        ont:clinical_observations    "nmp had no effect on survival in males or females, at any concentration. body weight, body weight gain and food consumption were lower over the 90-day feeding period at 18000 mg/kg, and during the first half of treatment at 7500 mg/kg. (the body weight gains over the 90-day test period were 28 and 25 % lower than control in the 18000 mg/kg males and females, respectively). neurobehavioral parameters were not affected, except from an increase in foot splay in males at 7500 and 18000 ppm, and a higher incidence of low arousal and slight palpebral closure in the open field evaluation in the 18000 ppm males. no morphological changes were evident in either the peripheral or central nervous system. the picture of effects was considered to be treatment-related and suggestive of a sedative effect." ;
        ont:compound                 <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:conclusion               "The NOAEL was 169 mg/kg bw/day in males and 217 mg/kg bw/day in females (3000 mg NMP/kg for both sexes) based on body weight effects and changes in three neurobehavioral parameters (males only) at higher doses." ;
        ont:critical_effect          "body weight effects and neurobehavioral changes" ;
        ont:description_pod          "noael mg nmp/kg, 169 mg/kg bw/day in males and 217 mg/kg bw/day in females based on body weight effects and changes in three neurobehavioral parameters (males only) at higher doses." ;
        ont:functional_observations  "lower body weight gain, sedative effect " ;
        ont:gross_pathology          "females had increased absolute and relative liver weights that were associated with an increased incidence of centrilobular hepatocellular hypertrophy (0/10 at 0, 3000 and 7500 mg/kg, and 6/10 at 18000 mg/kg). relative and absolute kidney weights were increased at 18000 mg/kg in both sexes, but no pathological changes were found. changes in the relative weight of lungs, brain (males and females), and testes (13% increase) occurred at 18000 mg/kg. they were not associated with morphological changes." ;
        ont:guideline                <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel           "non OECD" ;
        ont:haematology              "nmp had no effects haematology parameters in males or females, at any concentration" ;
        ont:point_of_departure       "3000" ;
        ont:purity                   "99.9" ;
        ont:species_strain           "rat/crl:cd" ;
        ont:type                     "in vivo" ;
        ont:urinalysis               "nmp had no effect on urinary parameters in males or females, at any concentration" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/127>
        a                           ont:Test ;
        ont:additional_info         "test substance: R0069279A" ;
        ont:blood_serum_biomarkers  "no test item-related changes in any of the parameters evaluated in clinical chemistry" ;
        ont:clinical_observations   "no clinical signs or mortalities in any of the groups during the treatment period. increase in absolute and relative liver weight was observed in high-dose males." ;
        ont:compound                <http://toxin.vub.be/resource/compound/Hydroxyethoxyphenyl%20Butanone> ;
        ont:concentration           "r0069279a 019 d 004" ;
        ont:conclusion              "based on the results of this 14-d oral repeat dose study, 100, 300 and 1000 mg/kg bw/d were chosen for the 90-day oral toxicity study" ;
        ont:gross_pathology         "no test item-related gross pathological findings in test-item treated animals. a dilatation of the uterus was observed in one female in the mid-dose and one female in the high-dose groups" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "no test item-related changes in any of the parameters evaluated in haematology and coagulation. in high-dose males, a 6% increase in mean platelet volume not accompanied by any significant changes in platelet count was also observed." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "rat/wistar" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "no test item-related changes in any of the parameters evaluated in urine" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/71>
        a                          ont:Test ;
        ont:additional_info        "test substance : bmhca" ;
        ont:clinical_observations  "no test substance related findings on clinical observations, body weights and food consumption were observed in all dosing groups. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "a diffuse degeneration of the seminiferous tubules combined with a moderate oligospermia and a moderate mixed inflammation in the epididymides was observed in 1/5 animals of the low dose group (30 mg/kg bw/day). in the mid-dose group, reduced testes and epididymides sizes with severe diffuse degeneration of seminiferous tubules and severe atrophy plus aspermia in the left epididymides was observed in 1/5 animals. a dose response relationship could not be observed. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rabbit/ himalayan" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/106>
        a                    ont:Test ;
        ont:additional_info  "test substance: sopp" ;
        ont:compound         <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:histopathology   "only bladder examined (once per week by TTEM). after 4 weeks an increase in dark-stained cells and a few mitoses were observed. the authors suggest that these changes are the prodromal stage of the tumours induced by SOPP after longer treatment periods." ;
        ont:species_strain   "rat/f344" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/50>
        a                       ont:Test ;
        ont:compound            <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:conclusion          "the loael for the adverse effects on the kidney was 0.73 mmol/kg bw/day (appr. 187 mg/kg bw/day)." ;
        ont:description_pod     "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:histopathology      "cytoplasmic vacuolation and hyperplasia of the proximal convoluted tubules were the most prominent alterations being observed from day 9 on. the number of affected cross sections showing cytoplasmic vacuolation was much greater in the kidneys of rats given 1876 mg/kg bw/day than in those given the lower dose. a higher incidence of basophilic tubules and of basophilic simple tubular hyperplasia was registered in both nta-treated groups compared to the control group. simple tubular hyperplasia associated with vacuolation increased in a dose-related manner and was only observed in nta-treated rats, but not in control animals. except one case in the low dose group, the development of tubular nodular hyperplasia was observed only in high dose rats. in addition vacuolation of epithelial cells were found in over 90% of the nodular hyperplastic lesions, the remaining were basophilic. beginning at day 13, changes in the renal pelvic transitional epithelium were observed in high dose animals. the development of focal haemorrhage, necrosis, erosion and hyperplasia of the epithelium of the renal pelvis were the most prominent lesions. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure  "92" ;
        ont:species_strain      "rat/sprague-dawley" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/29>
        a                       ont:Test ;
        ont:compound            <http://toxin.vub.be/resource/compound/vitamin%20a> ;
        ont:conclusion          "the authors fitted a regression curve to their data, which indicated a rise in the ratio of prevalence of birth defects associated to the cranial-neural crest at doses greater than 3000 mg re/day of vitamin a (food and supplement). the conclusions of the study remained the same when several potential confounding factors were considered. the quantitative conclusion from this study was that 3000 mg re/day of supplemental vitamin a can be considered as a threshold for teratogenicity, which would be associated with a low or negligible risk of teratogenicity" ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations  "women taking more than 4500 mg re of total vitamin a (from food and supplement) daily had a 3.5 times higher risk of giving birth to a child with cranial-neural-crest defects, than mothers ingesting less than 1500 mg re/day. when the analysis was restricted to the supplemental intake of vitamin a only, the relative risk for mothers ingesting more than 3000 mg re/day was 4.8 higher than those ingesting 1500 mg re/day. " ;
        ont:particle_size_and_procedure
                "the origin of the vitamin a intake (supplement or food) was available for all subjects" ;
        ont:species_strain      "human /pregnant" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/compound/sodium%20perborate%20%28tetrahydrate%29>
        a               ont:Compound ;
        rdfs:label      "sodium perborate (tetrahydrate)" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/sodium%20perborate%20%28tetrahydrate%29> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/135>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "limited clinical chemistry parameters were evaluated due to limitations in blood sampling; however, of the parameters measured, no consistent changes were noted." ;
        ont:composition             "soap" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:concentration           "0.1" ;
        ont:conclusion              "no differences were noted between animals sacrificed after 90 days of treatment and recovery animals. it showed that repeated exposure to triclosan (0.1% in a soap solution, 5 min exposure) was well-tolerated. no treatment-related toxicities were observed. " ;
        ont:gross_pathology         "termination examination showed no organ weight changes." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "mild anaemia, red blood cell and haemoglobin values showed variations between animals, but was not considered treatment-related. these changes were attributed to frequent sampling." ;
        ont:histopathology          "histopathologic evaluation revealed similar findings of focal adrenal mineralisation, pulmonary infiltration, and low-grade pneumonia in both treated and control animals. hepatocellular vacuolar changes and hepatic extramedullary haematopoiesis were observed in both treatment and control animals. no histological changes were observed in skin sections taken for examination. " ;
        ont:species_strain          "monkey/Rhesus" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/compound/p-aminophenol>
        a               ont:Compound ;
        rdfs:label      "p-aminophenol" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/p-aminophenol> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/79>
        a                           ont:Test ;
        ont:additional_info         "test substance: r0027494a, methylimidazoliumpropyl p-phenylenediamine, Cl, 2HCl (A166)" ;
        ont:blood_serum_biomarkers  "No treatment-related alterations were observed in clinical chemistry parameters of R0027494A treated groups when compared with the control group. No treatment related change in polychromatic to total erythrocytes ratio (P/E) was observed in all the R0027494A treated groups as compared to control group" ;
        ont:chemical_batch_nr       "008 l 002" ;
        ont:clinical_observations   "Some changes were observed in mean body weight gain of rats belonging to group G5 and in food consumption of female rats from groups G2, G3, G4 and G5 when compared to the G1 rats. These changes were limited, not dose related in female and therefore of uncertain biological significance." ;
        ont:composition             "the dose formulations were prepared by dissolving the test item in distilled water" ;
        ont:compound                <http://toxin.vub.be/resource/compound/methylimidazoliumpropyl%20p-phenylenediamine%20HCl> ;
        ont:conclusion              "Based on the results of the study, it is concluded that, with the exception of a slight decrease in body weight gain at the highest dose in males and a non dose-related decrease in body weight gain at all doses in females with a decreased food consumption in the two highest dosed groups, R0027494A did not produce any adverse effect up to the dose level of 1000 mg/kg b.wt./day when administrated through oral gavage for 14 consecutive days in Wistar rats under the conditions and the procedures followed in the present study. Consequently, the dose level of 1000 mg/kg b.wt./day can be selected as the highest dose to be tested for further repeated toxicity study." ;
        ont:gross_pathology         "No external and internal gross lesions were observed across all the groups." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "No treatment-related alterations were observed in haematology of R0027494A treated groups when compared with the control group" ;
        ont:histopathology          "No treatment related microscopic changes were observed in rats treated with R0027494A at 1000 mg/kg b.wt./day." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                  "99.9" ;
        ont:species_strain          "rat/wistar" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "No treatment-related alterations were observed in clinical chemistry parameters of R0027494A treated groups when compared with the control group" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/114>
        a                          ont:Test ;
        ont:additional_info        "test substance: Dowicide 1" ;
        ont:clinical_observations  "decreased (p<0.01) body weights occurred in males (10 %) and females (6 %) at 20000 ppm." ;
        ont:composition            "commercial grade Dowicide 1" ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:gross_pathology        "another effect observed at the highest dose level was increased relative testis weight (46 %)." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "extensive renal damage characterised by marked tubular dilation with varying degrees of acute and chronic inflammation was found in male and female animals at the highest dose" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "in the exposed as well as the control groups, only 22-32 % of the animals were alive at the end of 24 months." ;
        ont:species_strain         "rat/Wistar" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/6>
        a                           ont:Test ;
        ont:additional_info         "triclosan in toothpaste in 75 subjects;" ;
        ont:blood_serum_biomarkers  "for triglycerides, the triclosan group differed from the placebo group (p<0.01) at 3 weeks, but not at 12 weeks.  there was no difference between treatment and control groups for any of the other liver function tests." ;
        ont:composition             "triclosan in toothpaste" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:concentration           "0.2" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/58>
        a                          ont:Test ;
        ont:additional_info        "test substance:nta; calcium chelate of nta (CaNaNTA)" ;
        ont:clinical_observations  "the feeding did not affect food consumption, feed efficiency, or growth of any test group during the first 8 weeks of the study (no further record thereafter). " ;
        ont:compound               <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration          "0, 0.03, 0.15, 0.5,  0.5; 0.5" ;
        ont:conclusion             "the noael for renal toxicity was 0.03% NTA in diet (19 mg/kg bw/day) in this 2-year study" ;
        ont:description_pod        "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:gross_pathology        "liver body weight ratios were significantly higher than control values at 12 months for females receiving diets containing 0.5% nta.  in comparison to the control values, there was also a significant increase in the zinc level of bone in all test groups at nearly all check points during the experiment. the nta deposition in the bone increased related to the dose, remaining constant during treatment and without any difference between sexes. the breaking strength of the bones from treated rats was not significantly altered from that of the control animals." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "additional tissues taken for histologic examination after 19 and 24 months were spleen, liver, lung, heart, stomach, esophagus, small intestine, adrenal, trachea, urinary bladder, gonads, thyroid and bone (however no data were reported on the absence of evidence of abnormalities in these organs). the femurs were analysed for Zn and nta content and other parameters (dry and ash weight, percent ash, fat phosphorus, copper, magnesium, calcium).  no differences were noted microscopically in bones from test and control animals. in mid and high dose animals, lesions started at 6 months in 1 or 2 animals/group consisting of hydropic degeneration of the tubule and minor tubule dilatation. at 12 months they were still considered to be mild, although they were more pronounced and were apparently test related since 4/10 animals were affected by the 0.5% nta and 1/10 by the 0.15% nta dietary level. in addition to early changes tubular dilatation with low basophilic epithelium, hemosiderin in the tubular epithelium and proteinaceous casts in the collecting tubules were also apparent. the rats fed 0.03% nta did not exhibit these lesions and showed no differences from the control animals. at 24 months, moderate to severe chronic interstitial nephritis and nephrosis were observed with dose-related increase of incidence and severity in the mid and high dose groups of nta fed males and females (total incidence 42% and 55%). chronic renal lesions observed in 32% of the 0.03% nta groups did not show significant differences from that of control animals (28%). tumors of various types were reported to be similar for all groups and were considered not to be related to the treatment groups (details of incidences absent except for mammary gland tumors)." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "there was a dose related trend in survival rates in dosed nta-males, the survival rate was significantly lower in the high dose group." ;
        ont:point_of_departure     "92" ;
        ont:purity                 "92.2" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:target_organ           "kidney & urinary tract" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "a statistically significant increase in urinary zinc was intermittently noted in some rat groups receiving diets containing 0.15% and 0.5% nta." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/37>
        a                          ont:Test ;
        ont:clinical_observations  "after 7 to 15 daily treatments, the rabbits developed hind-limb weakness and diarrhoea. with continued treatment, weakness of both forelegs and death occurred. treatment was discontinued in three instances coinciding with the onset of severe quadraparesis in two animals and mild quadraparesis in the third rabbit. all three animals recovered. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "histopathological observation after autopsy of severely paralysed rabbits revealed no significant structural alterations in the brains, spinal cords, peripheral nerves, muscles, and abdominal or thoracic viscera in 8 of 12 rabbits. in the other four rabbits  various alterations in cns tissue were seen that the author associated with a protozoan infection. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rabbit" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/16>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "methemoglobin levels were significantly increased in the female treated at the dose of 10 mg/kg bw/day after 14 days treatment. this increase was also observed in males at the same dose but was not statistically significant.  bilirubin levels were also increased in the male rats treated at 10 mg/kg bw/day but this increase was not considered to be related to the tested compound." ;
        ont:chemical_batch_nr       "2097af, lot no. aj 3559" ;
        ont:clinical_observations   "no changes were observed in the body weight gains of the rats,or food consumption." ;
        ont:composition             "test substance in aqueous solution (bi-distilled water) + vehicle" ;
        ont:compound                <http://toxin.vub.be/resource/compound/acid%20orange%207> ;
        ont:conclusion              "on the basis of the results obtained in the 14-day dose range finding study, the following dose levels for the 90-day subchronic study were proposed: 0, 2.5, 5, 10 mg/kg bw/day." ;
        ont:gross_pathology         "no test compound related findings in organ weight were observed." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "heinz bodies were not reported in these animals" ;
        ont:histopathology          "no microscopic findings related to acid orange 7 were reported." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                  "90" ;
        ont:species_strain          "rat / hanibm:wist spf" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/dossier/vitamin%20a>
        a              ont:Report ;
        rdfs:label     "vitamin a" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/29> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/28> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/27> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/26> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/25> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_199.pdf> .

<http://toxin.vub.be/resource/dossier/hydroxypropyl%20p-phenylenediamine%20and%20its%20dihydrochloride%20salt>
        a              ont:Report ;
        rdfs:label     "hydroxypropyl p-phenylenediamine and its dihydrochloride salt" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/2> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_230.pdf> .

<http://toxin.vub.be/resource/compound/acid%20orange%207>
        a               ont:Compound ;
        rdfs:label      "acid orange 7" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/acid%20orange%207> .

<http://toxin.vub.be/resource/dossier/o-aminophenol>
        a              ont:Report ;
        rdfs:label     "o-aminophenol" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/125> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/124> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_025.pdf> .

<http://toxin.vub.be/resource/compound/HC%20Yellow%20n°%202>
        a               ont:Compound ;
        rdfs:label      "HC Yellow n° 2" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/HC%20Yellow%20n°%202> .

<http://toxin.vub.be/resource/compound/sodium%20perborate>
        a               ont:Compound ;
        rdfs:label      "sodium perborate" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/sodium%20perborate> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/143>
        a                          ont:Test ;
        ont:additional_info        "test substance: D5 (SF-1202)" ;
        ont:clinical_observations  "at necropsy, the heart, lungs, liver, kidneys, spleen, testes, epididymides, ovaries, and urinary bladder were weighed and preserved. no clinical signs of toxicity were observed. there was no effect on body weight, no mortality, no effect on organ weights, and no treatment related gross pathology findings. no signs of skin irritation were observed. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:species_strain         "rabbit/new zealand white" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/122>
        a                    ont:Test ;
        ont:additional_info  "test substance: SOPP" ;
        ont:composition      "Dowcide a, active ingredient OPP-Na x 4H2O, inert ingredient 3%" ;
        ont:compound         <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion       "tumours mainly occurred at doses from 15000 ppm with transitional cell carcinoma being the major histological type of tumour. the study revealed time- and concentration dependency of SOPP-induced urinary bladder tumour formation in male f344 rats." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:species_strain   "rat/F344" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/87>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:conclusion       "no compound-related dermal toxicity was observed" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rat/charles river cd" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/66>
        a                       ont:Test ;
        ont:additional_info     "test substance: cosmetic ingredient s02771" ;
        ont:compound            <http://toxin.vub.be/resource/compound/phenylene%20bis-diphenyltriazine> ;
        ont:description_pod     "loaec mg/L corresponding to 0.29mg/L for the ground active suabtance; loael mg/kg bw/day corresponding to 54 mg/kg bw/day  for for the ground active substance." ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure  "0.63; 115" ;
        ont:species_strain      "rat" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate>
        a               ont:Compound ;
        rdfs:label      "o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> .

<http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate>
        a               ont:Compound ;
        rdfs:label      "trisodium nitrilotriacetate" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/trisodium%20nitrilotriacetate> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/101>
        a                          ont:Test ;
        ont:additional_info        "test substance: HC Yellow n°4" ;
        ont:chemical_batch_nr      "22900186" ;
        ont:clinical_observations  "during the 6 month phase of this study, a decrease in the weight of rats from the high dose group when compared to controls was observed. this decrease was only significant in females during week 25. the low and mid dose level females also weighed significantly less than the controls during week 25. a significant decrease in food consumption was observed in females from the 0.1% dose group. significant changes in food consumption were not observed in males. in the recovery groups, males from the 0.1% and 0.3% dose groups exhibited a significant increase in body weights during week 14-27 except week 23 where it was only significantly increased in the rats treated at the dose of 0.3%. no significant changes in body weight were observed in females." ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:concentration          "0, 0.1, 0.3, 1.0" ;
        ont:conclusion             "hc yellow n°4 when fed to male and female rats at a dose level up to 1% in the diet is toxic, producing a significant decrease in body weights in the female rat and an increase in relative liver weight at all doses." ;
        ont:gross_pathology        "a significant increase in the relative weight of the liver was observed in rats from all treated groups. a significant decrease in the absolute and relative testes weight was observed in the high dose treated rats." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:purity                 "≈98.9" ;
        ont:species_strain         "rat/sprague-dawley (tac:n(sd)fbr)" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/45>
        a                          ont:Test ;
        ont:additional_info        "test substance: zinc omadine" ;
        ont:chemical_batch_nr      "108244691" ;
        ont:clinical_observations  "test substance related clinical observations were noted for the 5.0 mg/m3 group females. clinical observations included thin body condition in 2 additional females and impaired use of the hindlimbs in 1 female on study day 24. one female was also noted as hypothermic (body and extremities cool to the touch) on study day 26. test substance-related effects on body weights were noted in the 1.5 and 5.0 mg/m3 group males and females. body weight changes in the 5.0 mg/m3  group were considered to be adverse. during study days 0 to 4, lower mean food consumption, compared to the control group, was noted in the 5.0 mg/m3 group males and females and persisted in the 5.0 mg/m3 females throughout the study. exposure to the test substance at levels of 0.5 mg/m3 or higher resulted in an increase in the proportion of eosinophils in the bronchoalveolar lavage fluid (balf) of rats on study days 5, 12, and 26. minimal to mild increases in the proportions of neutrophils and lymphocytes were also considered to be test substance-related at levels of 0.5 mg/m3 and higher. balf findings also included higher incidence and severity of cell lysis at 0.5 mg/m3 or higher, and occasional erythrophagocytosis and mucous at 1.5 and 5.0 mg/m3, and rarely at 0.5 mg/m3 in females. higher balf lactate dehydrogenase and total protein levels were observed for males and females at all exposure levels on study days 5 and 12. higher total protein levels were also observed for 1.5 mg/m3 group females on study day 12 and higher ldh and total protein levels were also observed for the 5.0 mg/m3 group males and females on study day 26. the pneumonitis was characterised primarily by perivasculitis with an eosinophilic component, and less pronounced increase in mucus production within bronchioles, subacute inflammation of lung parenchyma, and increased numbers of alveolar macrophages. there was no apparent difference in the incidence or severity of broncho-interstitial pneumonitis in the lungs between the necropsies on study days 5, 12, or 26. however, effects on both lung weights and balf percent eosinophils in the 1.5 and 5.0 mg/m3  groups were less pronounced following 4 weeks of exposure than following 1 or 2 weeks of exposure. for broncho-interstitial pneumonitis in the lung, as well as lung weights and balf percent eosinophils, effects appeared to be more pronounced in females than in males. smooth muscle hypertrophy of the alveolar ducts in the lungs, which was observed in all test substance-exposed groups as early as the study day 5 necropsy, increased in incidence and severity with increasing exposure concentration, and with increasing time on the study." ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion             "based on local (portal of entry) effects that were observed at exposure levels of 0.5 mg/m3 or higher, no noaec could be derived. the loaec for local effects is 0.5 mg/m3. based on systemic endpoints including survival, clinical observations, body weights, food  consumption, organ weights, and microscopic examination of selected tissues (brain, liver, kidneys, stomach, and skeletal muscle), authors considered the noaec for systemic toxicity as 1.5 mg/m3" ;
        ont:critical_effect        "survival, clinical observations, body weights, food  consumption, organ weights, and microscopic examination" ;
        ont:description_pod        "loaec mg/m3;  noaec mg/m3" ;
        ont:gross_pathology        "zpt exposure was associated with test substance-related and adverse necropsy and microscopic findings including lower final body weight in the 5.0 mg/m3 group males, higher lung weights in both sexes of all groups, lower thymus weights in the 5.0 mg/m3 group animals, and broncho-interstitial pneumonitis and smooth muscle hypertrophy in the lungs of both sexes at all exposure levels following 1, 2, and 4 weeks of exposure. test substance-related enlargement of the mediastinal lymph nodes was observed in 1 male and 1 female in the 1.5 mg/m3 group and in 1 female in the 5.0 mg/m3 group (study day 12) and enlargement of the bronchial lymph nodes was observed in 3 females in the 5.0 mg/m3 groups (study days 5 or 12)" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "test substance-related enlargement of the mediastinal lymph nodes was observed in 1 male and 1 female in the 1.5 mg/m3 group and in 1 female in the 5.0 mg/m3 group (study day 12) and enlargement of the bronchial lymph nodes was observed in 3 females in the 5.0 mg/m3  groups (study days 5 or 12). for these gross lesions, mild to moderate lymphoid hyperplasia was observed microscopically. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "one female of the highest dose group was found dead on study day 15." ;
        ont:point_of_departure     "0.5; 1.5" ;
        ont:purity                 "98.3" ;
        ont:species_strain         "rat / sprague-dawley (crl:cd)" ;
        ont:target_organ           "lung, thymus, lymph nodes, " ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/24>
        a                          ont:Test ;
        ont:additional_info        "test substance: 2-phenoxyethanol" ;
        ont:clinical_observations  "at 2000 mg/kg bw/day, clinical signs including occasional episodes of prostration and lethargy, females were more affected than males. these episodes occurred as isolated or low-incidence events when dosing was initiated and resolved with continued dosing. food intake of males at the highest dose was decreased to 94% of controls. the body weights of high-dose male and female rats were decreased by about 17 and 7%, respectively." ;
        ont:compound               <http://toxin.vub.be/resource/compound/phenoxyethanol> ;
        ont:conclusion             "the noel in this study was reported as 80 mg/kg bw/day based on the finding of inflammation in the kidney in males at 400 mg/kg bw/day." ;
        ont:critical_effect        "inflammation in the kidney" ;
        ont:description_pod        "noel mg/kg bw/day" ;
        ont:gross_pathology        "liver, kidney and thyroid weights were increased at 2000 mg/kg bw/day" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "at highest dose, toxicity to red blood cells and other effects that are associated with this phenomenon (decreased erythrocyte number, decreased packed cell volume and decreased haemoglobin concentration, and kidney inflammation with epithelial cells and polymorphonuclear leukocytes in the urinary sediment) at 2000 mg/kg bw/day." ;
        ont:histopathology         "inflammation of the kidneys was also seen in males at 400 mg/kg bw/day. minor testicular changes were noted in a few high-dose male rats, but these changes were considered to be of equivocal toxicological significance." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "five animals, 1 female (mid dose) and 4 males (1 low dose, 2 mid dose, one high dose) died during treatment for unknown reasons and probably not treatment-related. four high-dose females died with one death caused by bronchopneumonia and other without a gross or histopathological changes" ;
        ont:physical_form          "translucent colourless liquid" ;
        ont:point_of_departure     "80" ;
        ont:species_strain         "rat/sprague dawley cd" ;
        ont:target_organ           "kidney" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/compound/triclosan>
        a               ont:Compound ;
        rdfs:label      "triclosan" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/triclosan> .

<http://toxin.vub.be/resource/compound/hydroxypropyl%20p-phenylenediamine%20and%20its%20dihydrochloride%20salt>
        a               ont:Compound ;
        rdfs:label      "hydroxypropyl p-phenylenediamine and its dihydrochloride salt" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/hydroxypropyl%20p-phenylenediamine%20and%20its%20dihydrochloride%20salt> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/95>
        a                            ont:Test ;
        ont:clinical_observations    "nasal irritation as shown by crust formation on nasal edges at 1000 mg/m³ was observed at the end of the exposure period. at 3000 mg/m³, non-specific clinical symptoms and irritation of the respiratory tract were registered. in male rats, body weight was significantly decreased (34%) .examination of the satellite group at the end of the 4-week post-exposure observation period showed a significant lower body weight gain in males compared with the controls." ;
        ont:compound                 <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:description_pod          "noael mg NMP/m³ for both male and female" ;
        ont:functional_observations  "nasal irritation, lower body weight gain, haematological parametrs alteration, cell loss in germinal epithelium of testes" ;
        ont:gross_pathology          "in male rats absolute testes weight was decreased.  the testes effects registered in the 3000 mg/m³ group sacrificed at the end of exposure were also registered in the satellite group at the end of the 4-week post-exposure observation period." ;
        ont:guideline                <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel           "non OECD" ;
        ont:haematology              "in male rats slight increases in erythrocytes, haemoglobin, haematocrit, and mean corpuscular volume were observed. in female rats, the number of polymorphonuclear neutrophils increased and the number of lymphocytes decreased. " ;
        ont:histopathology           "cell loss in germinal epithelium of testes in 4 out of 10 male rats was noted. the testes effects registered in the 3000 mg/m³ group sacrificed at the end of exposure were also registered in the satellite group at the end of the 4-week post-exposure observation period." ;
        ont:particle_size_and_procedure
                "the generated NMP atmospheres consisted of a large proportion (82–92%) of respirable aerosol particles (MMAD 2.1–3.5 µm; relative humidity 52–61%)." ;
        ont:point_of_departure       "500" ;
        ont:species_strain           "rat" ;
        ont:type                     "in vivo" ;
        ont:urinalysis               "dark yellow discoloration of the urine was found at all levels," .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/130>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "blood values for serum glucose, uric acid, and creatinine concentrations, and for alkaline phosphatase and serum glutamic-pyruvic transaminase activities were within normal ranges for dogs of all groups. concentrations of BUN usually were within normal ranges except for two control female dogs and one low dosage male at the twelve month test interval. at this time, these dogs showed BUN values of 40-45 mg/100ml. at 18 months the BUN for these three dogs were in the range of 15-25 mg/100ml. all animals in both test groups excreted blue-brown coloured urine daily." ;
        ont:clinical_observations   "all dogs gained body normal weight.  no noteworthy differences between control and test animal organ weights were seen for any of the organ-to-body-weight ratios." ;
        ont:composition             "a hair dye composite material containing 15 hair dye substances" ;
        ont:compound                <http://toxin.vub.be/resource/compound/HC%20Yellow%20n°%202> ;
        ont:concentration           "0.28" ;
        ont:gross_pathology         "no gross or microscopic changes were seen in the various tissues and organs that could be attributed to the test material." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "haematology values were within normal limits." ;
        ont:histopathology          "no ultra-structural changes were observed in the electron microscopic studies conducted on sections of liver and urinary bladder from all dogs sacrificed at 18 months." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "dog/purebred beagle" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "urine analyses showed no remarkable findings at any examination period. colour was normal in the urines collected following overnight fasting and was probably an indication of clearance" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/74>
        a                          ont:Test ;
        ont:additional_info        "test substance : bmhca suspended in fluid baby food" ;
        ont:clinical_observations  "no effects on body weights or histopathological alterations in the testis were noted." ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:conclusion             "general and testicular toxicity was not observed under the conditions of this study." ;
        ont:gross_pathology        "minimal inflammatory reaction was found in one epididymis of one animal and small hollow spaces in the epithelium of one epididymis of the other. the testes of both animals were found free of lesions" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "monkey rhesus / macaca mulatta" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/1>
        a                          ont:Test ;
        ont:additional_info        "test substance: 2-phenoxyethanol" ;
        ont:clinical_observations  "signs of toxicity were characterised by anorexia, lethargy and excretion of dark-red urine. on day 5, mean body weights of rabbits dosed with 100, 300, or 600 mg/kg bw/day had decreased approximately 8% from their pre-exposure weights and 10-14% from that of control animals. on day 10, rabbits in the 100 and 300 mg/kg/day dose groups continued to show similar decreases in body weight." ;
        ont:compound               <http://toxin.vub.be/resource/compound/phenoxyethanol> ;
        ont:description_pod        "loael  mg/kg bw/d" ;
        ont:gross_pathology        "most rabbits administered 1000 or 600 mg/kg bw/day exhibited gross pathological alterations consistent with haemolytic anaemia including enlarged and dark kidneys and spleen, dark urine in the urinary bladder, and dark urine staining the perineal region. conversely, rabbits gavaged with 100 or 300 mg/kg bw did not have treatment-related gross lesions. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "in general, rabbits exposed to 2-phenoxyethanol had decreased rbc count, hgb concentration and pcv, with concurrent increases in nucleated and poly-chromatophilic red blood cells. many animals exhibiting severe depressions in rbc numbers also showed concurrent increases in mch, mchc, platelets and wbc. the values for mch and mchc were considered elevated due to free haemoglobin in plasma" ;
        ont:histopathology         "treatment-related microscopic changes were observed in rabbits from all dose levels. splenic microscopic changes included red pulp congestion and erythro-phagocytosis in most animals of both high dose groups. treatment-related microscopic changes also occurred in the kidneys and stomach of both high-dose groups. the spleen of one rabbit in the 300 mg/kg/day dose group had thrombi in venous sinuses resulting in generalised splenic necrosis. this animal also had thrombi within pulmonary blood vessels. two rabbits given 100 mg/kg/day had splenic extramedullary haematopoiesis." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "during the 10-day treatment period, deaths occurred in all dose groups above 100 mg/kg bw/day or animals were sacrificed moribund." ;
        ont:point_of_departure     "100" ;
        ont:species_strain         "rabbit/new zealand white" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "urine samples collected from rabbits in the 1000, 600 and 300 mg/kg/day dose groups exhibited decreased pH in combination with elevated levels of protein, bilirubin, urobilirubin and haemoglobin. decreases in urinary pH and increases in urinary bilirubin and rbc were observed in at least one rabbit in the 100 mg/kg/day dose group." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/109>
        a                           ont:Test ;
        ont:additional_info         "test substance: SOPP" ;
        ont:blood_serum_biomarkers  "no other toxic effects based on remaining clinical chemistry" ;
        ont:clinical_observations   "LM and SEM in 3 males and females of control and 2.0% group at 4, 8 and 13 weeks. reduced body weight gain in males at 1 and 2% and in both sexes at 4%. reduced mean food intake in both sexes at 4%.  no other toxic effects based on remaining urinary parameters, haematology, clinical chemistry, gross necropsy and full routine histopathology. no abnormal findings in the bladder epithelium of the 2% group at 4, 8, and 13 weeks based on LM and SEM." ;
        ont:compound                <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:gross_pathology         "no other toxic effects based on remaining gross necropsy" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "no other toxic effects based on remaining haematology" ;
        ont:histopathology          "no other toxic effects based on  full routine histopathology. no abnormal findings in the bladder epithelium of the 2% group at 4, 8, and 13 weeks based on LM and SEM." ;
        ont:species_strain          "mouse/b6c3f1" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "increased urinary pH value and decreased urine density at 4% in both sexes. no other toxic effects based on remaining urinary parameters," .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/53>
        a                          ont:Test ;
        ont:clinical_observations  "no adverse effects were observed grossly in any study. growth, organ to body weight ratios (no data on organ weight) were within the normal limits. " ;
        ont:composition            "aqueous solution of nta" ;
        ont:compound               <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration          "2.5" ;
        ont:conclusion             "no indication for systemic effects was observed. however, systemic bioavailability of nta is considered to be questionable, the data reported were incompliant to standard test design and therefore a n(l)oael for systemic toxicity cannot be derived. " ;
        ont:description_pod        "noael for local effect %, 50 mg/kg bw/day" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "haematologic values were within the normal limits" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:physical_form          "liquid" ;
        ont:point_of_departure     "2.5" ;
        ont:species_strain         "rabbit/new zealand" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/32>
        a                          ont:Test ;
        ont:additional_info        "test substance: zpt" ;
        ont:clinical_observations  "orally administered zpt in a shampoo formulation produces a reversible paralysis in rats and rabbits within one to two weeks at levels of 10 mg/kg/day. a dose level of 10 mg/kg/day of zpt in shampoo was used in a monkey gavage study which lasted 16 weeks. no adverse effects were observed. because of the emetic potential of shampoos, oral dosing of dogs has not produced any toxic symptoms, including ocular effects. " ;
        ont:composition            "shampoo formulations containing zpt" ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rat; rabbit; monkey; dog" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/11>
        a                          ont:Test ;
        ont:additional_info        "test substance: hc red n° 3" ;
        ont:chemical_batch_nr      "lot 5890377" ;
        ont:clinical_observations  "rat: differences in mean body weight gains were not dose related; mouse: mean body weight gains were comparable between dosed or control groups." ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20red%20n°%203> ;
        ont:description_pod        "noael, mg/kg bw/d in rat; in mouse" ;
        ont:gross_pathology        "dark thyroid glands were observed in 5/5 male rats that received 1000 mg/kg/d, 2/5 males that received 500 mg/kg/d and 2/5 males that received 250 mg/kg/d. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "no histopathology examination was performed" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure     "1000; 500" ;
        ont:purity                 "97" ;
        ont:species_strain         "rat / f344/n; mouse / b6c3f1" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "rat & mouse: the urine of all dosed animals was maroon to orange throughout the studies." .

<http://toxin.vub.be/resource/compound/disperse%20violet%201>
        a               ont:Compound ;
        rdfs:label      "disperse violet 1" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/disperse%20violet%201> .

<http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204>
        a               ont:Compound ;
        rdfs:label      "hc yellow n° 4" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/hc%20yellow%20n°%204> .

<http://toxin.vub.be/resource/dossier/disperse%20violet%201>
        a              ont:Report ;
        rdfs:label     "disperse violet 1" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/23> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_028.pdf> .

<http://toxin.vub.be/resource/dossier/acid%20orange%207>
        a              ont:Report ;
        rdfs:label     "acid orange 7" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/18> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/17> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/16> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/15> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_158.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/138>
        a                    ont:Test ;
        ont:additional_info  "test substance: d5" ;
        ont:compound         <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:conclusion       "statistical comparison of mean body weight and food consumption data indicated no treatment-related effects between the control and the test groups. a statistically significant increase in absolute liver weight was observed in female rats treated with 1500 mg D5/kg bw/day (23% compared to the control group)." ;
        ont:gross_pathology  "no gross pathological changes were observed in any of the organs or tissues of male and female rats in the control and test groups." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:species_strain   "rat/sprague-dawley" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/82>
        a                          ont:Test ;
        ont:additional_info        "test substance: p-aminophenol$" ;
        ont:clinical_observations  "at 467 mg/kg bw, both sexes were observed to have reduced body weight gain and food consumption. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:gross_pathology        "increased relative liver, kidney, and brain weights in both sexes and increased relative pituitary and thyroid weights in females were attributed to compound administration." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "female rats had significantly lower haemoglobin and erythrocyte counts and increased corpuscular haemoglobin levels, but these changes were without clinical significance" ;
        ont:histopathology         "nephrosis was observed in all groups, including controls, but the incidence and severity of this change increased in a dose-dependent fashion" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/117>
        a                          ont:Test ;
        ont:additional_info        "test substance: OPP" ;
        ont:chemical_batch_nr      "mixture #8800005-24" ;
        ont:clinical_observations  "no treatment-related effects were identified from clinical observations and haematology. body weight reduction occurred with no concurrent reductions in food consumption: at 2 years, the mid- and high-dose females had body weights reduced by 13 % (p<0.05) and 20 % (p<0.05), respectively, whereas the mid and high-dose males had body weights reduced by 7 % (statistically not significant) and 13 % (p<0.05), respectively.  " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion             "as treatment-related effects were observed in all dose groups, no NOAEL can be derived from this study. the LOAEL is considered to be 250 mg/kg bw/d." ;
        ont:description_pod        "LOAEL  mg/kg bw/d" ;
        ont:gross_pathology        "Liver was identified as a further target: increased (p<0.05) relative liver weights occurred in each of the OPP-treated male and female groups at the interim sacrifice and in the mid- and high-dose groups at terminal sacrifice." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/OECD%20TG%20453> ;
        ont:guidelineLabel         "OECD TG 453" ;
        ont:histopathology         "renal tubular epithelial cells in sexually mature males had lipid vacuoles and every male exposed to OPP had decreased vacuolation in renal tubular epithelial cells, starting with the low dose. all groups exposed to OPP for 1 year as well as 2 years exhibited an increase (p<0.05) in the incidence of an accentuated lobular pattern (an area wherein cells were larger and their cytoplasm showed increased eosinophilia). increased (p<0.01) incidences of adenoma occurred in the terminal sacrifice males at the mid and high doses. although the treatments did not affect the incidence of carcinoma in the males, the terminal sacrifice groups at the low, mid, and high doses had a rarely observed variant of hepatocellular carcinoma, hepatoblastoma. only the incidence of hepatoblastoma at the mid dose was statistically significant (p<0.05), however. the combined incidence of hepatoblastoma and/or hepatocellular carcinoma was not significantly increased in livers of male mice, however, a statistically significant increase in hepatocellular adenoma was observed at the two highest doses (27/50 in controls, 33/50 at 250 mg/kg, 40/50 at 500 mg/kg, and 41/50 at 1000 mg/kg). in female mice, also microscopic changes in livers were seen, however, no female mouse had a hepatoblastoma and there were no statistically significant increases in liver or other tumours in the female animals." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "OPP did not affect survival of the interim sacrifice animals (both sexes) and the terminal sacrifice males. low and mid-dose females at terminal sacrifice had the largest numbers of animals not surviving to terminal sacrifice" ;
        ont:point_of_departure     "250" ;
        ont:purity                 "99.88" ;
        ont:species_strain         "mouse/ B6C3F1" ;
        ont:target_organ           "kideny, liver" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/9>
        a                   ont:Test ;
        ont:composition     "silicon dioxide-based toothpaste containing 0.243% fluoride and 0.3% triclosan" ;
        ont:compound        <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion      "no treatment-related changes were reported for any parameter measured, including haematology, clinical chemistry, and urinalysis parameters. the data shows that the use of toothpaste containing 0.3% triclosan produces no adverse effects compared to triclosan-free toothpaste formulations" ;
        ont:guideline       <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel  "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain  "human" ;
        ont:type            "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/61>
        a                    ont:Test ;
        ont:additional_info  "test substance: not specified perborate" ;
        ont:compound         <http://toxin.vub.be/resource/compound/sodium%20perborate> ;
        ont:conclusion       "in conclusion the noel for these endpoints is below the dose of 1000 mg/kg bw/d tested. this study was only for 6 days with 8 days of recovery and only a limited number of parameters have been investigated." ;
        ont:gross_pathology  "no effects on the stomach were found in this study in rats receiving 1000 mg/kg bw/d." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:haematology      "no changes in blood cell parameters were observed during the study but haemoglobin and haematocrit were increased up to 15 days after the end of the application. this was explained by depression of haematopoiesis during the study and overregulation at the termination of the application." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rats" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/40>
        a                          ont:Test ;
        ont:additional_info        "test substance: zpt." ;
        ont:clinical_observations  "after four weeks no skin irritations or other toxicity was observed for animals treated with 0.4 and 2.0% concentration of zpt. animals treated with 20% zpt showed thickening of the skin and erythema. no hind-limb paralysis as observed in rats or rabbits was seen in any of the groups." ;
        ont:composition            "test substance in a 1% surfactant/0.5% thickener vehicle" ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:concentration          "0.4, 2.0, 10.0, 20.0" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "mouse" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/19>
        a                          ont:Test ;
        ont:chemical_batch_nr      "ar92-020420" ;
        ont:clinical_observations  "reddish faeces in all test groups (dose related severity). body weight: no treatment-related changes, food intake: no treatment-related changes " ;
        ont:compound               <http://toxin.vub.be/resource/compound/acid%20red%2092> ;
        ont:conclusion             "10, 50 and 250 mg/kg bw/day were selected as dose levels for a subsequent 13-wk study." ;
        ont:gross_pathology        "organ weights: no treatment-related changes" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "percentage of basophils decreased in high-dose females, platelet count increased in high-dose females" ;
        ont:histopathology         "stomach irritation in both sexes at 50 and 250 mg/kg bw/day (focal spongiosis of the limiting ridge in high-dose group both sexes and dyskeratosis in mid- and high dose females)." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                 "94-99.5" ;
        ont:species_strain         "rat/ hanbrl : wist (spf)" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/dossier/Hydroxyethoxyphenyl%20Butanone>
        a              ont:Report ;
        rdfs:label     "Hydroxyethoxyphenyl Butanone" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/127> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_225.pdf> .

<http://toxin.vub.be/resource/compound/β-arbutin>
        a               ont:Compound ;
        rdfs:label      "β-arbutin" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/β-arbutin> .

<http://toxin.vub.be/resource/dossier/sodium%20perborate%20%28tetrahydrate%29>
        a              ont:Report ;
        rdfs:label     "sodium perborate (tetrahydrate)" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/63> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/62> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/60> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_031.pdf> .

<http://toxin.vub.be/resource/dossier/resorcinol>
        a              ont:Report ;
        rdfs:label     "resorcinol" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/65> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/64> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_015.pdf> .

<http://toxin.vub.be/resource/dossier/HC%20Yellow%20n°%202>
        a              ont:Report ;
        rdfs:label     "HC Yellow n° 2" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/130> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/129> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/128> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_038.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/90>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "except from a lower serum alp in females at 4060 mg/kg bw/day, there were no changes in the clinical chemistry parameters" ;
        ont:clinical_observations   "morphological examination revealed pathological changes, consistent with the renal effects observed in the surviving animals. there was no effect on body weight or food consumption, or changes in haematological parameters at any doses, in either males or females. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:critical_effect         "histopathology of kidneys" ;
        ont:description_pod         "noael mg/kg bw/day (2500 mg/kg) in males;  mg/kg bw/day (7500 mg/kg) in females, based on the kidney histopathology" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "cloudy swelling of the epithelia of the distal parts of the renal tubuli was observed in 4 males and 3 females at 10 000 mg/kg and in 2 males at 7500 mg/kg." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "death of one male in the 2670 mg/kg bw/day group was considered treatment-related" ;
        ont:point_of_departure      "720; 2970" ;
        ont:purity                  "99.9" ;
        ont:species_strain          "mouse/b6c3f1/crlbr" ;
        ont:target_organ            "kidney" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/125>
        a                    ont:Test ;
        ont:additional_info  "test substance: o-aminophenol" ;
        ont:composition      "hair dye fomulation mixed with an equal volume of 6% H2O2" ;
        ont:compound         <http://toxin.vub.be/resource/compound/o-aminophenol> ;
        ont:concentration    "0.3" ;
        ont:conclusion       "no evidence of toxicity was seen and no effect on body weight and urinalysis was observed. scattered statistically significant differences in clinical chemistry and haematological values were seen which were considered of no toxicological significance." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:species_strain   "rabbit/new zealand white" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/compound/phenoxyethanol>
        a               ont:Compound ;
        rdfs:label      "phenoxyethanol" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/phenoxyethanol> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/69>
        a                          ont:Test ;
        ont:additional_info        "test substance : bmhca" ;
        ont:clinical_observations  "loss of hair, hunched posture and lethargy were noted in the 2 highest dose groups, haematuria and paresis of the forelegs were noted in the highest dose group. an initial loss of body weight was observed at 50 – 400 mg/kg bw/day." ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:conclusion             "subacute administration of bmhca to male rats led to treatment-related effects at ≥50 mg/kg bw/day including dose-related testicular findings. from this study the noael derived was suggested at 25 mg/kg bw/day. the noael of 25 mg/kg bw/day has been confirmed in a subsequent study (refs.: givaudan, 1991, rifm #16176). " ;
        ont:description_pod        "noael mg/kg bw/d" ;
        ont:gross_pathology        "gross findings included mild liver effects in some rats at 50 – 200 mg/kg bw/day and in all rats at 400 mg/kg bw/day group, small prostate (100 – 400 mg/kg bw/day), and small seminal vesicles (200 – 400 mg/kg bw/day), and reddened testes in 1/8 rats at 200 mg/kg bw/day and in 6/8 rats at the highest dose group. kidney weights were decreased in the high dose group, and a dose-related decrease in the testes weights was observed at doses of ≥100 mg/kg bw/day. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "histology of the testes revealed degeneration and loss of germ cells in the seminiferous epithelium at ≥50 mg/kg bw/day." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure     "25" ;
        ont:species_strain         "rat" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/104>
        a                    ont:Test ;
        ont:additional_info  "test substance: SOPP" ;
        ont:compound         <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration    "0, 0.25, 0.5, 1.0, 2.0" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:histopathology   "10 animals from each group killed in weeks 4, 8, 12, 24 and 36 and subjected to bladder histopathology and SEM; remaining rats kept until week 104 and subjected to histopathology. hyperplasia of bladder starting in 2% animals after 4 weeks, increasing severity until week 104; at 36 weeks hyperplasia also in other groups. for 2% animals: no development of papilloma until week 36; papilloma in 2 of 5 rats killed in week 104. no development of carcinoma until week 36; carcinoma in 2 of 5 rats killed in week 104. for 1% animals: no development of PN hyperplasia, papilloma or carcinoma until week 104; simple hyperplasia from week 36. no findings at lower doses." ;
        ont:purity           "97" ;
        ont:species_strain   "rat/f344" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/48>
        a                          ont:Test ;
        ont:additional_info        "test substance: sodium omadine 41.2 % aqueous solution" ;
        ont:chemical_batch_nr      "8508-p-166h" ;
        ont:clinical_observations  "there were no treatment-related clinical signs. palpable masses were rare and only 4 were confirmed as tumours. body weight was not affected by treatment," ;
        ont:composition            "aqueous solution of the test substance" ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion             "dermal administration of NaPT had no effect on tumour incidence. thus, based on the results of this study, NaPT induced slight histopathologic changes at the treatment site but did not influence tumour formation. " ;
        ont:critical_effect        "local effect (epidermal hyperplasia)" ;
        ont:description_pod        "noael mg/kg bw/d" ;
        ont:gross_pathology        "kidney weights of all treated females were slightly reduced dose-dependently. in view of the absence of pathologic findings in kidneys, this was considered as not of toxicological relevance." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "leucocyte differential counts were not different between treated and control groups." ;
        ont:histopathology         "at the site of treatment, increased incidences of epidermal hyperplasia were observed in both sexes at 15 and 40 mg/kg/d. the effect was statistically significant at the highest dose. no treatment-related effects on sceletal muscle or sciatic nerve were observed in that study." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "28 male and 44 female animals died or were killed in extremis. deaths were considered not treatment-related." ;
        ont:point_of_departure     "5" ;
        ont:purity                 "41.2" ;
        ont:species_strain         "mouse / crl:cd-1 (icr) br (vaf plus)" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/dossier/acid%20red%2092>
        a              ont:Report ;
        rdfs:label     "acid red 92" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/19> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_087.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/27>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "changes in lipid metabolism, resulting in a 2-3% increase in blood cholesterol concentration in a placebo-controlled trial which could lead to an increased risk of cardiovascular disease." ;
        ont:composition             "retinol equivalence" ;
        ont:compound                <http://toxin.vub.be/resource/compound/vitamin%20a> ;
        ont:description_pod         "loael µg retinol equivalence /day" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "7500" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/98>
        a                          ont:Test ;
        ont:additional_info        "test substance: HC Yellow n°4" ;
        ont:chemical_batch_nr      "0-218" ;
        ont:clinical_observations  "rats: all animals survived to the end of the studies. the final mean body weights of male that received doses of 10000 ppm and above and females that received doses of 20000 ppm or 40000 ppm were significantly lower than those of controls. feed consumption by males in all dose groups was generally higher than that of the controls throughout the study. feed consumption by females that received 40000 ppm was generally higher than that of the controls. feed consumption by females in other dose groups was lower than that of the controls. the values for feed consumption by rats receiving 40000 ppm were nearly twice that of other groups and are probably due to spillage of unpalatable diet. no clinical findings were attributed to HC Yellow n°4 administration. mice:  the final mean body weights and mean body weight changes of males and females that received doses of 10000 ppm were significantly lower than those of controls. high feed consumption by dosed mice was observed, particularly by those received the three highest dose levels, maybe due to spillage of unpalatable feed and therefore might not reflect the actual amount of feed consumed. no biologically significant clinical findings were observed that were related to HC Yellow n° 4 administration. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:conclusion             "rats: the decreases in mean body weights of male rats in the 10000, 20000 and 40000 ppm dose groups were considered quite dramatic (8%, 19% and 29%) and suggested that for male rats, 10000 ppm may exceed an exposure compatible with long-term survival in the 2-year study, thus doses of 2500 and 5000 ppm were selected for the males in the 2 year study. in the females, the weight decreases were much less dramatic (20000 ppm 5%, 40000 ppm 11%) but all females receiving 20000 ppm or more had uterine atrophy. thus, doses of 5000 and 10000 ppm were selected for the female rats in the 2-year study. mice: a combination of deaths and decreased mean body weights relative to controls precluded the selection of doses above 10000 ppm. therefore, doses of 5000 and 10000 ppm were selected for mice in the 2-year studies." ;
        ont:critical_effect        "rat: decreased body weight in males and uterine atrophy in females/ mouse: death and decreased body weight" ;
        ont:description_pod        "NOAEL ppm, rats in male equivalent to 250 mg/kg/d bw, in female rats equivalent to 500 mg/kg/d bw; NOAEL ppm in male and female mice equivalent to 750 mg/kg/d bw" ;
        ont:gross_pathology        "rat: significant changes in absolute and relative organ weights were observed but were considered to be secondary to decreases in body weights. Mouse: statistically significant changes in absolute and relative organ weights were considered to reflect decreases in body weight." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "rat: lesions related to chemical administration were seen in the thyroid gland of males and females, the kidney in males and the uterus in females. a mineralization of the renal papilla occurred in all male rats in the 40000 ppm dose. thyroid pigmentation occurred in male and female rats receiving 40000 ppm. uterine atrophy occurred in female rats in the 20000 and 40000 ppm groups. the severity of all lesions ranges from minimal to mild except for uterine atrophy in the 40000 ppm female group which ranged from mild to moderate. mouse: thyroid pigmentation occurred in mice at all dose levels. minimal to mild uterine atrophy occurred in female mice in the 40000 and 80000 ppm groups. lymphoid depletion and subsequent atrophy of the spleen and thymus occurred in male and female mice that received 80000 ppm. these findings were considered to be secondary to the decreased body weights in these groups. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "mice: 8 males and 7 females in the 80000 ppm dose groups died; 9 of these deaths occurred during week 1, 5 occurred during week 2 and 1 occurred during week 11. one male that received 40000 ppm died during week 7." ;
        ont:point_of_departure     "5000, 10000; 5000" ;
        ont:purity                 "> 93" ;
        ont:species_strain         "rat/f344/n;  mice/b6c3f1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/133>
        a                           ont:Test ;
        ont:additional_info         "test substance: triclosan" ;
        ont:blood_serum_biomarkers  "dose-related increases in leukocyte count. alterations in serum chemistry such as glutamic-pyruvic transaminase, alkaline phosphatase were observed. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion              "the NOAEL for inhaled triclosan was determined to be the lowest dose tested." ;
        ont:description_pod         "NOAEL mg/m3" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "Slight focal inflammation of the mucous membranes was observed in high-dose animals at the end of the study." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "although there were 12 unscheduled deaths related to high-dose level exposure, 11 of the 12 rats died during day 1 as a result\nof the very high initial doses. necropsy revealed congestion, inflammatory changes in mucous membranes and nasal cavity." ;
        ont:point_of_departure      "50" ;
        ont:species_strain          "rat" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/4>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "limited clinical chemistry parameters were evaluated due to limitations in blood sampling; however, of the parameters measured, no consistent changes were noted. " ;
        ont:composition             "soap" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:concentration           "0.1" ;
        ont:conclusion              "no differences were noted between animals sacrificed after 90 days of treatment and recovery animals.showed that repeated exposure to triclosan (0.1% in a soap solution, 5 min exposure) was well-tolerated." ;
        ont:gross_pathology         "termination examination showed no organ weight changes." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "mild anaemia, red blood cell and haemoglobin values showed variations between animals, but was not considered treatment-related. these changes were attributed to frequent sampling." ;
        ont:histopathology          "histopathologic evaluation revealed similar findings of focal adrenal mineralisation, pulmonary infiltration, and low-grade pneumonia in both treated and control animals. hepatocellular vacuolar changes and hepatic extramedullary haematopoiesis were observed in both treatment and control animals. no histological changes were observed in skin sections taken for examination." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations      "no treatment-related toxicities were observed." ;
        ont:species_strain          "monkey/rhesus" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/77>
        a                           ont:Test ;
        ont:additional_info         "test substance: BMHCA" ;
        ont:blood_serum_biomarkers  "increase in glutamate dehydrogenase and alanine aminotransferase levels with body weight reduction  in one animal" ;
        ont:clinical_observations   "the study revealed occasional vomiting in both animals, diarrhoea in one animal and body weight reduction together with an increase in glutamate dehydrogenase and alanine aminotransferase levels" ;
        ont:compound                <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "Histological examinations showed multifocal inflammation in the liver and mild atrophy in seminiferous tubules (necrosis of germ cells, multinucleated giant cells in tubular lumen)." ;
        ont:species_strain          "dogs" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/112>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "exp1: 1, 2 or 4 intravesical instillations into urinary bladder of saline, NaOH (solution adjusted to pH 11.1), 0.1 % SOPP, 0.1 % PBQ or 0.1 % PHQ; 2-3 rats/group killed 24 hr, 4d and 7d after last injection; LM analysis of  bladder.. experiment 2: investigation of tumor- initiating potential of chemicals; intravesical instillations into urinary bladder of 0.1% PBQ or 0.1% PHQ or 2.0 ml saline twice a week for 5 weeks followed by 31 weeks basal diet with or without 5% sodium saccharin. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration          "0.1" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "exp 1: occasional slight inflammation and epithelial hyperplasia with SOPP and PHQ; inflammation and hyperplasia of bladder mucosa, papillary or nodular hyperplasia after PBQ treatment. exp 2: BBN group:2 bladder papilloma, 9 pn hyperplasia, 11 simple hyperplasia. SOPP and PHQ: no hyperplastic changes. PHQ: pn and/or simple hyperplasia in 9 animals." ;
        ont:pH_adjustment          "11.1" ;
        ont:species_strain         "rat/f344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/56>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "mean fasting blood glucose levels were elevated in all groups receiving NTA comparing to control values. the increased glucose levels at all doses were considered as treatment-related but not clearly adverse." ;
        ont:clinical_observations   "no difference in total body weight or weight gain was observed in 0.01 and 0.1% levels of nta in the drinking water after ten weeks of treatment" ;
        ont:compound                <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration           "0.01, 0.1, 1" ;
        ont:conclusion              "the noael limited to the parameters of this test was 0.01% (approx. 10 mg/kg bw/day)." ;
        ont:description_pod         "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:gross_pathology         "at 0.1% nta the relative kidney weight was elevated." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "histology of the organs examined did not differ from that of control animals. in contrast, kidneys from the 1% NTA group showed marked vacuolization of renal tubules. brain and pancreas of these animals were not examined microscopically, livers were normal. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "there was one early death in the mid dose group and a high mortality rate in the high dose group. six animals died within four weeks, and remaining animals appeared moribund and were killed. " ;
        ont:point_of_departure      "92" ;
        ont:species_strain          "rat/sprague-dawley" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "urine volume of any of the nta test groups did not differ from controls, but glycosuria was present in 5/7 of rats receiving 1% nta." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/35>
        a                       ont:Test ;
        ont:additional_info     "test substance: sodium pyrithione" ;
        ont:compound            <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:critical_effect     "hind limb muscle atrophy (neurotoxic effect)" ;
        ont:description_pod     "noel mg/kg/d" ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure  "0.5" ;
        ont:species_strain      "rat/sprague-dawley" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/14>
        a                          ont:Test ;
        ont:additional_info        "test substance: hc red n° 3" ;
        ont:clinical_observations  "no noteworthy differences were seen in any of the parameters studied between the controls and the animals receiving 19.5 or 97.5 mg/kg bw/day. all dogs gained weight normally and survived to end of the 104 weeks." ;
        ont:composition            "hair dye formulation containing test substance" ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20red%20n°%203> ;
        ont:concentration          "0.02" ;
        ont:conclusion             "the authors concluded that oral dosing exposure of a hair dye formulation containing 0.02% hc red n° 3 in formulations up to 97.5 mg/kg bw/day did not result in any signs of toxicity." ;
        ont:gross_pathology        "no gross or microscopic changes were seen in the various tissues and organs that could be attributed to the test material." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "no ultra-structural changes were observed in the electron microscopic studies conducted on sections of liver and urinary bladder." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "dog/ beagle" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "all dogs in the two test groups excreted urine of a bluebrown colour on a daily basis. however urine analysis showed no remarkable findings. colour was normal in urine collected after overnight fasting." .

<http://toxin.vub.be/resource/compound/o-aminophenol>
        a               ont:Compound ;
        rdfs:label      "o-aminophenol" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/o-aminophenol> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/141>
        a                          ont:Test ;
        ont:additional_info        "test substance: D5" ;
        ont:clinical_observations  "no overt signs of toxicity were reported." ;
        ont:compound               <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:critical_effect        "results indicate repeated inhalation exposure to d5 induced an early non-sustained increase in liver weight and an early burst of hepatocellular hyperplasia and centrilobular hypertrophy in female rats exposed to concentrations of 160 ppm." ;
        ont:gross_pathology        "absolute and relative liver weights were increased 12, 11 and 6% (absolute) and 10, 8 and 7% (relative) compared to control after 1, 2 and 4 five day exposure periods, respectively. thyroid weights were not affected by treatment." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "a statistically significant increase in the incidence of hepatocellular hyperplasia was reported after the first and fourth 5-day exposure period, which returned to near control levels after 2 and 4- five days exposure periods. a slight but significant increase (< 2 fold) in the incidence of thyroid hyperplasia was reported following the 2nd and 4th five-day exposure period. " ;
        ont:species_strain         "rat/Fischer 344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/85>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:concentration    "0.087" ;
        ont:conclusion       "no compound-related histopathological effects were observed" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rat/sprague-dawley" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/120>
        a                      ont:Test ;
        ont:additional_info    "test substance: SOPP (Dowicide a)" ;
        ont:chemical_batch_nr  "MM01044" ;
        ont:compound           <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration      "0, 0.125, 0.25, 0.5, 1.0, 2.0, 4.0 " ;
        ont:conclusion         "it can be concluded that SOPP causes tumours in the urinary bladder and kidneys of the rat" ;
        ont:guideline          <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel     "non OECD" ;
        ont:histopathology     "tumours of the urinary bladder, the renal pelvis and renal papilla developed. all of these tumours were transitional cell carcinomas except one carcinosarcoma occurring at the 2% dose. an increased incidence of carcinoma of in the renal papilla was observed at 4.0 %, whereas carcinoma in the renal papilla occurring between 0.5 and 4.0 % did not reach statistical significance. with respect to bladder, a dose-related increase in the incidence of tumours of the urinary system between the 0.5 and the 2.0 % level but not up to the highest dose level. further, at 2.0 % the first carcinoma appeared in week 55, whereas at 4.0 % the first tumour appeared in week 74. the dose relationship of tumour incidence might have been influenced by the dose-dependent reduction in survival. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate     "survival was 90 %, 90 %, 95%, 90 %, 90 %, 57 % and 70 % in rats fed 0, 62, 125, 250, 500, 1000 and 2000 mg/kg bw/d." ;
        ont:purity             "≥ 95" ;
        ont:species_strain     "rat/ F344/Du" ;
        ont:type               "in vivo" ;
        ont:urinalysis         "hematuria was observed at all dose levels from week 45." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/64>
        a                          ont:Test ;
        ont:clinical_observations  "rat: no differences in final body weight, clinical signs of toxicity appeared within one-half hour after dosing and lasted 1 to 2 hours. hyperexcitability and tachypnoea were observed in males from the 225 and 450 mg/kg bw/d groups. females receiving doses of 55 mg/kg bw/d and above showed hyperexcitability and those receiving 110 and 450 mg/kg bw/d showed tachypnoea; mice : final body weights of surviving dosed mice were similar to those of the controls. clinical findings including prostration and tremors were recorded among males from the 150, 300, and 600 mg/kg bw/d groups, and among females from the 300 and 600 mg/kg bw/d groups. absolute and relative thymus weights were statistically significantly decreased in high-dose females in comparison to the control. clinical signs in both rats and mice appeared usually within one-half hour after dosing and lasted 1 to 2 hours in surviving animals. no biologically significant changes in organ weights." ;
        ont:compound               <http://toxin.vub.be/resource/compound/resorcinol> ;
        ont:conclusion             "based on the clinical signs reported, the esfa panel concluded that the noael in rats was 27.5 mg resorcinol/kg bw/d. based on the clinical effects reported the esfa panel concluded that the noael in mice was 75 mg/kg bw/d." ;
        ont:description_pod        "noael mg/kg bw/d in rats; mice" ;
        ont:gross_pathology        "in both species no gross lesions attributable to resorcinol administration were observed" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "in both species no microscopic lesions attributable to resorcinol administration were observed" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no; yes" ;
        ont:mortality_rate         "rat: 0; mice: all females and four males receiving 600 mg/kg bw/day and one male receiving 300 mg/kg bw/d died as a result of the resorcinol administration" ;
        ont:point_of_departure     "27.5; 75" ;
        ont:species_strain         "rat/ f344/n; mice/b6c3f1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/43>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "no significant changes in plasma, rbc or brain cholinesterase was observed at any dose tested for any time point measured. " ;
        ont:clinical_observations   "low muscle tone was observed at 150 and 200 mg/kg/d in male animals beginning on day 8 and day 11 that continued throughout the study duration. in female animals low muscle tone was observed at 50, 75 and 100 mg/kg/d beginning on day 8 in the 100 mg/kg/d group, on day 15 in the 75 mg/kg/d group and on days 22-28 in the 50 mg/kg/d group. muscle tone and body weight were decreased in male animals of the two highest doses on days 14 and 28. hindlimb and forelimb grip strength were decreased in male animals of the two highest doses on days 14 and 28. decreases in the electrophysiological measurements measured as the maximum amplitude were observed in males at 150 mg/kg/d. in females on day 14 grip strength was reduced in the 75 and 100 mg/kg/d group and on day 28 grip strength was reduced in the three highest dose groups. again in females, decreases in the electrophysiological values measured as the maximum amplitude were observed in the 50 and 75 mg/kg/d group (electrophysiological measurements not taken at the 100 mg/kg/d dose level)." ;
        ont:compound                <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:critical_effect         "effect on the hindlimb" ;
        ont:description_pod         "noael mg/kg bw/day female; male" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "25; 50" ;
        ont:species_strain          "rat/sprague-dawley" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/compound/toluene-2%2C5-diamine%20and%20its%20sulfate>
        a               ont:Compound ;
        rdfs:label      "toluene-2,5-diamine and its sulfate" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/toluene-2%2C5-diamine%20and%20its%20sulfate> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/22>
        a                           ont:Test ;
        ont:additional_info         "test substance: cetrimonium bromide" ;
        ont:blood_serum_biomarkers  "no compound related changes were observed in haematological and clinical laboratory analyses of blood" ;
        ont:clinical_observations   "10 mg/kg bw/day: - slightly increased body weight (not statistically significant); 20 mg/kg bw/day: - slightly increased body weight (not statistically significant); 45 mg/kg bw/day: - significantly reduced mean body weights in both sexes after 3 weeks, persisting till end of study in males and for 9 weeks in females - males: significantly decreased efficiency of food conversion, - significantly reduced skeletal growth (judged by the growth of the tail) in both sexes - wetting and discoloration of ventral fur, often associated with a brown discoloration of the fur " ;
        ont:compound                <http://toxin.vub.be/resource/compound/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride> ;
        ont:conclusion              "the authors conclude that cetrimonium bromide, when continuously administered in large doses, may potentially prevent proper nutrition by increasing the rate of gastric emptying and intestinal transit and/or by interfering with the absorption of nutritional substances." ;
        ont:description_pod         "noael mg/kg bw/d" ;
        ont:gross_pathology         "20 mg/kg bw/day: - increased relative caecum weight in males. 45 mg/kg bw/day: - males: reduced relative liver weight - increased relative caecum weight in both sexes. no gross necropsy changes were seen" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "no microscopic alterations were found in the wall of stomach and small intestine of treated rats. no other tissues were subjected to histopathological examination." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations      "no compound related changes were observed in haematological" ;
        ont:point_of_departure      "10" ;
        ont:species_strain          "rat/sprague dawley" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "no compound related changes were observed in clinical laboratory analyses of urine." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/93>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "at 2500 and/or 7500 mg/kg bw/day, increase in serum cholesterol (females), and decreases in serum triglycerides, calcium, and alp (males) occurred at 28 days, but not at 90 days." ;
        ont:clinical_observations   "there was no adverse effect on survival, body weight, food consumption or haematological parameters at any dose, in either males or females.  " ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:conclusion              "The NOAEL was set at 277 mg/kg bw/day (1000 mg/kg) based on the liver responses at higher doses. (Transient changes in biochemical parameters were also observed at > 1000 mg/kg)." ;
        ont:description_pod         "noael mg/kg bw/day (1000 mg/kg) based on the liver responses at higher doses. (transient changes in biochemical parameters were also observed at > 1000 mg/kg)." ;
        ont:gross_pathology         "liver weight (absolute and relative) was increased in males at 2500 and 7500 mg/kg. relative liver weight was also slightly higher at all doses in females, although a dose-response relationship was not evident." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          " centrilobular hepatocellular hypertrophy was observed at 7500 mg/kg (1/10, 0/10, 2/10, and 9/10 in males at 0, 1000, 2500, and 7500 mg/kg, respectively; and 1/10, 0/10, 3/10, and 10/10 in females at 0, 1000, 2500, and 7500 mg/kg, respectively). these findings were regarded as an adaptation process, but were clearly attributed to nmp exposure. no other histopathological changes were detected." ;
        ont:point_of_departure      "277" ;
        ont:purity                  "99.9" ;
        ont:species_strain          "mouse/b6c3f1" ;
        ont:target_organ            "liver" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/128>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "statistically significant changes in a few clinical chemistry  parameters; however, these changes were not considered to be toxicologically meaningful." ;
        ont:chemical_batch_nr       "GTS03975 (lot code : #17)" ;
        ont:clinical_observations   "test article-related clinical signs included abnormal coloured dark yellow or orange urine and yellow or orange staining of the tail and hair coat. no statistically significant or toxicologically meaningful differences in mean body weights, body weight changes, food consumption or organ weight data.  " ;
        ont:compound                <http://toxin.vub.be/resource/compound/HC%20Yellow%20n°%202> ;
        ont:conclusion              "oral administration of the test substance daily for 14 consecutive days up to 600mg/kg bw/d did not produce any treatment-related mortality or clinical signs of toxicity. in addition, there were no remarkable changes in the clinical pathology data, gross necropsy data, or organ weight data to suggest a treatment-related effect" ;
        ont:gross_pathology         "gross changes observed at necropsy were unremarkable" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "statistically significant changes in a few haematology parameters; however, these changes were not considered to be toxicologically meaningful." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "there were no treatment-related mortalities noted during this study. one control male was found dead on study day 2. however, gross necropsy revealed that this death was due to mechanical injury. all remaining animals survived to scheduled euthanasia. " ;
        ont:purity                  "99.9" ;
        ont:species_strain          "rat/Sprague-Dawley, Crl:CD®(SD)IGS BR" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/72>
        a                          ont:Test ;
        ont:additional_info        "test substance : bmhca" ;
        ont:chemical_batch_nr      "00036077l0" ;
        ont:clinical_observations  "retardation of body weight gain or body weight loss together with decreases in food efficiency were observed in combination with vomitus and soft faeces/diarrhoea in all animals at ≥200 mg/kg bw/day. a range of clinical parameters were altered in highly dosed animals." ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:gross_pathology        "liver weight increases between 30-40% above control values, and centrilobular hypertrophy of hepatocytes were observed at ≥200 mg/kg bw/day. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "massive diffuse degeneration of seminiferous tubules combined with hyperplasia of Leydig cells in testes and aspermia and epithelial vacuolation in the epididymides was found in one dog in the mid-dose group." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                 "99.1" ;
        ont:species_strain         "dog /beagle" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/107>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "sacrifice after 3, 7, 14, 30, 65 and 90 d; blood, urine, liver, kidney and urinary bladder samples examined at each time point. reduced food intake and body weight decrease returned to normal after 2 weeks. " ;
        ont:composition            "72% SOPP; 25.6% water, 1.05% NaOH " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "increased rate of mitosis in the bladder epithelium from day 3 (although declining over time, the rate was still elevated at the end of the study). increased thickness of the bladder epithelium from day 14 until end of study (classified as hyperplasia with accompanying increased frequency of cell infiltration). no tumours of urinary bladder." ;
        ont:species_strain         "rat/f344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/51>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "clinical chemistry examinations did not reveal changes of the levels of iron concentrations, transferrin levels and total iron binding capacity. " ;
        ont:clinical_observations   "at 20000ppm group some of the animals showed piloerection from day 21 on. at this dose level food consumption was decreased up to 48% during the entire study and water consumption increased up to 102% of the controls. the body weights were significantly lower (-26%) than in the contol groups." ;
        ont:compound                <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:conclusion              "the noael of this study was 150 ppm NTA.H2O (9 mg/kg bw/day)." ;
        ont:critical_effect         "tubular hyperplasia, basophilia, vacuolation (without hyperplasia), dilation, calcification of tubules, interstitial nephritis, inflammation, necrosis, fibrosis and urothelial hyperplasia of the renal papilla and pelvic dilation. " ;
        ont:description_pod         "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:gross_pathology         "all animals at 20000ppm showed enlarged kidneys and dilation of the renal pelvis. the ureters were dilated in one animal." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "microscopic lesions were seen in the kidney of all high dose animals consisting of tubular hyperplasia. these hyperplasias were characterised by tubules with large, vacuolized cells. other changes in most or all animals of this group were basophilia, vacuolation (with hyperplasia), dilation and calcification of tubules, interstitial nephritis, inflammation, necrosis, fibrosis and urothelial hyperplasia of the renal papilla and pelvic dilation. ultra structurally, the histomorphological vacuolation of tubular epithelial cells were confirmed to consist of different stages of vesiculation and dilation of the rough endoplasmic endothelium, occasionally accompanied by cytoplasmic blebbing into the tubular lumen, and of ballooning degeneration of mitochondria. these changes were found in samples of the cortex and outer medulla, but not in the inner medullar regions. they are characteristic for different stages of cell swelling and vacuolar degeneration up to lysis of cells. no renal lesions except a single animal with tubular calcification and two animals with mononuclear cell infiltration were observed in the low dose group. no lesions related to the nta treatment were observed in the liver, pancreas, and spleen. the observed lesions of other subgroups were in accordance with the described and therefore not separately reported." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "one animal at highest dose ( 20000 ppm) died on day 28" ;
        ont:point_of_departure      "92" ;
        ont:purity                  "92.4" ;
        ont:species_strain          "rat/wistar" ;
        ont:target_organ            "kidneys, ureters and urinary bladder" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "at 20000ppm group, all animals had red-brown discoloured urine from day 9 to the end of the study. quantitative measurements in the urine revealed increased activities of ldh on day 2,4 and 8 of the study. at day 8, ϒ-ggt and creatinine concentrations were reduced. increased concentrations of zinc were excreted with the urine at the end of the study, but calcium and iron excretion remained unaffected. standard urinalysis revealed macrohematuria on day 8, increased blood and in the sediment elevated number of erythrocytes on day 4,8 and 29. the urine specimens were discoloured from dark yellow to light brown and appeared cloudy on days 2, 4 and 8. decreased amounts of urinary crystals were found on day 2,4 and 8 and increased numbers of transitional epithelial were found on day 4 and 8 of the treatment." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/30>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "some slight changes serum chemistry  were observed, though no dose-dependency could be observed and the observed changes were small and reported to be within the normal ranges for the tested species." ;
        ont:chemical_batch_nr       "lot a" ;
        ont:clinical_observations   "no test substance-related clinical signs. neither did body weight gain and food consumption differ between control and treated animals during the dosing period." ;
        ont:compound                <http://toxin.vub.be/resource/compound/β-arbutin> ;
        ont:conclusion              "no changes attributed to β-arbutin were observed up to a dosage of 1000 mg/kg bw/day. this can be considered as the noel value" ;
        ont:description_pod         "noel mg/kg bw/day" ;
        ont:gross_pathology         "necropsy at the end of the dosing period revealed some spontaneous anomalies, but no test compound-related changes. " ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "some slight changes in haematological were observed, though no dose-dependency could be observed and the observed changes were small and reported to be within the normal ranges for the tested species. " ;
        ont:histopathology          "there were no histopathological findings related to administration of the test substance" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "1000" ;
        ont:purity                  "99.7" ;
        ont:species_strain          "rat/spraque dawley (spf crj:cd)" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "some slight changes in urine parameters were observed, though no dose-dependency could be observed and the observed changes were small and reported to be within the normal ranges for the tested species. " .

<http://toxin.vub.be/resource/compound/boron%20compounds>
        a               ont:Compound ;
        rdfs:label      "boron compounds" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/boron%20compounds> .

<http://toxin.vub.be/resource/compound/Methoxypropylamino%20Cyclohexenylidene%20Ethoxyethylcyanoacetate%20%28S87%29>
        a               ont:Compound ;
        rdfs:label      "Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (S87)" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/Methoxypropylamino%20Cyclohexenylidene%20Ethoxyethylcyanoacetate%20%28S87%29> .

<http://toxin.vub.be/resource/dossier/n-methyl-2-pyrrolidone%20%28NMP%29>
        a              ont:Report ;
        rdfs:label     "n-methyl-2-pyrrolidone (NMP)" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/95> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/89> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/94> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/90> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/91> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/88> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/92> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/93> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_050.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/136>
        a                          ont:Test ;
        ont:additional_info        "test substances: boric acid and disodium tetraborate decahydrate" ;
        ont:clinical_observations  "clinical signs included coarse hair coats, hunched position, and inflamed bleeding eyes, desquamation of the skin of the tail and the pads of the paws which were also swollen, marked respiratory involvement, shrunken appearance of the scrotum were observed in all males of the high dose group. in addition a reduction in body weight was observed in males and females in the high dose group accompanied by decreased food consumption." ;
        ont:compound               <http://toxin.vub.be/resource/compound/boron%20compounds> ;
        ont:conclusion             "based on the clinical and haematological effects and the testicular atrophy observed at the highest doses tested (58.5 mg b/kg bw/day) of both boric acid and disodium tetraborate decahydrate the noael for the effects of boron was set at 17.5 mg b/kg bw/day (eu, 2009a). " ;
        ont:description_pod        "NOAEL mg b/kg bw/day" ;
        ont:gross_pathology        "testicular atrophy and seminiferous tubule degeneration was observed at 6, 12 and 24 months at the highest dose level with both boric acid and disodium tetraborate decahydrate." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "decreased red cell volume and haemoglobin were observed in boric acid and disodium tetraborate decahydrate treated rats. at the end of the study the values in all dosed animals were reduced compared to control. significant reduction of red blood cell volume and haemoglobin was mainly observed in high dosed males treated with boric acid (at the end of the study 5% to 21% and 7% to 19% reduction compared to control, were observed for red blood cell volume and haemoglobin, respectively), but also in the females treated with boric acid a significant reduction of haemoglobin at all dose groups was detected at the last measurement (between 8% and 13%). for disodium tetraborate decahydrate blood of the high dosed animals showed reduced values for both endpoints in males and females at several time points. " ;
        ont:histopathology         "microscopic examination of the tissue revealed atrophied seminiferous epithelium and decreased tubular size in the testes. no effects were observed in the control and low dose groups." ;
        ont:point_of_departure     "17.5" ;
        ont:species_strain         "rat / Sprague-dawley" ;
        ont:target_organ           "haematopoietic system" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/80>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol$" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:conclusion       "no compound-related toxicity was observed" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rat/wistar" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/115>
        a                          ont:Test ;
        ont:additional_info        "test substance: Dowicide 1" ;
        ont:chemical_batch_nr      "MM01040" ;
        ont:clinical_observations  "increased water intake at 531 and 1140 mg/kg bw/d and up to 8 % and 12 % reduced body weights at 531 and 1140 mg/kg bw/d – the latter finding most probably due to reduced food intake." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration          "0, 0.625, 1.25, 2.5" ;
        ont:gross_pathology        "affected organs were kidneys, urinary bladder and spleen. the absolute spleen weight was decreased by 16 – 24 % in all treated groups." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "increased (20 %) white blood cell count at the highest dose" ;
        ont:histopathology         "tissue, findings, at dose 0 [mg/kg bw/d]; 269 [mg/kg bw/d]; 531 [mg/kg bw/d]; 1140 [mg/kg bw/d] / kidneys, hyperplasia 0/24 (0 %); 0/20 (0 %); 0/24 (0 %); 12/23 (52%), pyelonephritis 0/24 (0 %); 0/20 (0 %); 1/24 (4 %); 15/23 (65%), interstitial nephritis 0/24 (0 %); 0/20 (0 %); 2 (24) (8 %); 8/23 (35%), combined incidences of pyelonephritis and interstitial nephritis 0/24 (0 %); 0/20 (0 %); 3/24 (13 %); 23/23 (100%) / urinary bladder, simple hyperplasia 0/24 (0 %); 2/20 (10 %); 0/24 (0 %); 7/23 (30%), papilloma 0/24 (0 %); 0/20 (0 %); 3/24 (13 %); 2/23 (8%), carcinoma 0/24 (0 %); 0/20 (0 %); 20/24 (83%); 2/23 (8%), combined papilloma and carcinoma incidences 0/24 (0 %); 0/20 (0 %); 23/24 (96%); 4/23 (17%) " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "survival was 100 %, 71 % (p < 0.05) and 65 % (p < 0.05) at 269, 531 and 1140 mg/kg bw/d, respectively. " ;
        ont:purity                 "> 98" ;
        ont:species_strain         "rat/ F344/DuCrj" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "hematuria at 531 and 1140 mg/kg bw/d," .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/7>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "biochemical analyses showed increases in sodium, cholesterol (total, ldl, and hdl), uric acid, and creatinine and decreases in bilirubin at all time points in the study in either males or females or both sexes. the average triclosan concentration in the blood of 15.5 ng/mL was reported to rise to 31.2 ng/mL after a period of 4 weeks on study. this concentration was reported to subsequently level off with further use of the triclosancontaining dentifrice. " ;
        ont:composition             "toothpaste containing 0.2% of triclosan and 0.5% zinc citrate" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:concentration           "0.2" ;
        ont:conclusion              "these changes were not attributed to triclosan." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "the data showed increases in white blood cells and lymphocytes throughout the study, with decreases in mean corpuscular haemoglobin/concentration" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/59>
        a                           ont:Test ;
        ont:additional_info         "test substance: toluene-2,5-diamine sulfate" ;
        ont:blood_serum_biomarkers  "several biochemistry parameters were influenced at and above 30 mg/kg bw/d (ast, cpk, ldh, alt (only at 60 mg/kg bw/d))" ;
        ont:chemical_batch_nr       "ch 1143" ;
        ont:clinical_observations   "no treatment related clinical observations were recorded and body weight and food intake were not changed." ;
        ont:compound                <http://toxin.vub.be/resource/compound/toluene-2%2C5-diamine%20and%20its%20sulfate> ;
        ont:conclusion              "treatment-related myofiber necrosis, degeneration, and/or inflammatory change were present in skeletal muscle, tongue, and diaphragm of both males and females given 30 or 60 mg/kg bw/d in this study and that the noael for muscle degenerative change in this study was 15 mg/kg bw/d." ;
        ont:critical_effect         "muscle degeneration" ;
        ont:description_pod         "noael mg/kg bw/day" ;
        ont:gross_pathology         "at necropsy no macroscopic abnormalities were noted. the mean absolute and relative (to body weight) liver weights of both sexes at 60 and males only at 30 mg/kg bw/d were increased." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "no haematological parameters were altered" ;
        ont:histopathology          "myocyte degeneration was noted in the heart, skeletal muscle, tongue and diaphragm in both sexes in all dose groups" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "one animal died after blood withdrawal which was not associated with the test substance." ;
        ont:point_of_departure      "15" ;
        ont:purity                  "99.7" ;
        ont:species_strain          "rat/sprague-dawley crl:cd(sd)br" ;
        ont:target_organ            "heart, skeletal muscle, tongue and diaphragm" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/38>
        a                          ont:Test ;
        ont:clinical_observations  "no difference was noted in skin effects. no effects on the eye were seen in either group." ;
        ont:composition            "5 ml of a 20% aqueous paste of a commercial soap with or without 1 % zpt (on a soap basis)" ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:concentration          "20" ;
        ont:gross_pathology        "no difference was noted in gross or microscopic pathology between the test group and the control group treated with soap alone." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "histopathologic study of the brains of both groups revealed changes frequently seen in laboratory rabbits that are thought to be associated with the protozoan organism encephalitozoon cuniculi. this condition is spontaneous, is seen with great frequency, and is mild chronic in nature. there were no compound-related lesions" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rabbit" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/17>
        a                          ont:Test ;
        ont:chemical_batch_nr      "fda certified material" ;
        ont:clinical_observations  "no evidence of systemic toxicity, growth responses were normal" ;
        ont:composition            "test substance acid orange 7 dissolved in water as well as usp white ointment" ;
        ont:compound               <http://toxin.vub.be/resource/compound/acid%20orange%207> ;
        ont:concentration          "0.1 & 1" ;
        ont:gross_pathology        "fross autopsies disclosed no dose-related findings." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "haematological values were normal" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rabbit" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "urinary components were normal" .

<http://toxin.vub.be/resource/dossier/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride>
        a              ont:Report ;
        rdfs:label     "alkyl (C16, C18, C22) trimethylammonium chloride" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/22> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/21> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/20> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_012.pdf> .

<http://toxin.vub.be/resource/compound/2%2C7-naphthalenediol>
        a               ont:Compound ;
        rdfs:label      "2,7-naphthalenediol" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/2%2C7-naphthalenediol> .

<http://toxin.vub.be/resource/compound/hc%20red%20n°%203>
        a               ont:Compound ;
        rdfs:label      "hc red n° 3" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/hc%20red%20n°%203> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/88>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "in both sexes lymphocyte count decreased following exposure to 1028 and 2060 mg/kg bw/day" ;
        ont:clinical_observations   "in males, a dose-dependent decrease was observed in body weight at 1028 and 2060 mg/kg bw/day (11% and 16%, respectively). in both sexes, a dose-dependent decrease in body weight gain were observed at 1028 and 2060 mg/kg bw/day. symptoms of general toxicity, such as tremor, restlessness, ruffled fur, and defensive reactions, were registered. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:critical_effect         "body weight decreased, lymphocyte count decreased" ;
        ont:description_pod         "noael mg /kg bw" ;
        ont:gross_pathology         "a decrease in relative and absolute testes weight was observed in nine male animals at 2060 mg/kg bw/day. in both sexes, a dose-dependent increase in relative liver and kidney weights was observed at 1028 and 2060 mg/kg bw/day, " ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "the histological examination in males showed adverse effects on seminiferous tubule epithelium and formation of multinucleate giant cells and clumping of sloughed-off cells." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "514" ;
        ont:species_strain          "rat" ;
        ont:target_organ            "general toxicity, testes, liver, kidney, " ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/123>
        a                           ont:Test ;
        ont:additional_info         "test substance: SOPP" ;
        ont:blood_serum_biomarkers  "apart from dose-dependently increased serum alp levels on females, there were no statistically significant haematological differences between treated and control animals." ;
        ont:chemical_batch_nr       "04279A" ;
        ont:clinical_observations   "body weights were significantly reduced in 2.0 % males, in 2.0 % females from week 13, in 1.0 % females from week 26 and in 0.5 % females from week 38.  " ;
        ont:compound                <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration           "0, 0.5, 1.0, 2.0 " ;
        ont:conclusion              "with respect to hepatic tumours, the authors state that statistically significantly increased incidence of hepatocellular carcinomas in 1 % and 2 % males might be due to an unusual low incidence in control mice (8.2 %) which was in contrast to the average spontaneous rate of this tumour in that lab (20.1 %). with respect to the increase of haemangiosarcomas in 1 % males the authors concluded that the finding was fortuitous as changes were due to unusually low incidences in in control animals and not dose-related" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "histopathology revealed a variety of non-neoplastic and neoplastic lesions. non-neoplastic lesions were e.g.: cystic endometrial hyperplasia of the uterus in 0.5 % females, increased inflammation of the eye in 0.5 % females, increased calcification of the brain in 2.0 % females. there was a significant decrease in haemangiomas and leiomyosarcomas in the uteri of all SOPP- treated groups compared to controls. neoplastic lesions reaching statistical significance were an increase in haemangiosarcoma of the liver in 1 % (incidence: 10 %; statistically not significant) males and a significantly increased number of mice with hepatocellular carcinomas in 1 % (incidence: 26 %; p< 0.05) and 2 % (p< 0.01) (incidence: 28 %) males. papillomas and cancers of the urinary bladder did not occur in the treated animals. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "survival rate of rats fed 0, 0.5, 1.0 and 2.0 % SOPP was 70, 66, 68 and 54 % for males and 78, 68, 78 and 82 % for females, respectively. " ;
        ont:purity                  "97" ;
        ont:species_strain          "mouse/B6C3F1" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/compound/Hydroxyethoxyphenyl%20Butanone>
        a               ont:Compound ;
        rdfs:label      "Hydroxyethoxyphenyl Butanone" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/Hydroxyethoxyphenyl%20Butanone> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/67>
        a                       ont:Test ;
        ont:additional_info     "test substance:  2,7-dihydroxynaphthalene" ;
        ont:composition         "aqueous suspension" ;
        ont:compound            <http://toxin.vub.be/resource/compound/2%2C7-naphthalenediol> ;
        ont:conclusion          "the dose of 60 mg/kg bw/day represents the dose with the noael." ;
        ont:description_pod     "noael mg/kg bw/d" ;
        ont:gross_pathology     "the highest test dose produced weight increase in liver, spleen and kidney, " ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:histopathology      "the highest test dose produced liver pigmentation, increased haematopoiesis in the spleen, and hyaline deposition in the kidney. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations  "the other doses (20 and 60 mg/kg bw/day) did not show clinical, biochemical and pathological-anatomical signs of a systemic cumulative toxicity." ;
        ont:physical_form       "liquid" ;
        ont:point_of_departure  "60" ;
        ont:species_strain      "rat/wistar (mu ra han 67 spf)" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/102>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP, Dowicide A" ;
        ont:chemical_batch_nr      "MM01044" ;
        ont:clinical_observations  "body weights significantly lower in 2% males and 0.5, 2 and 4 % females (not in 1% females) during the whole treatment period and transiently in 1% males (up to week 3).  " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration          "0, 0.125, 0.25, 0.5, 1.0, 2.0, 4.0" ;
        ont:critical_effect        "in 4% males: pyelonephritis as predominating effect (60%; p≤0.01); in 2% males: neoplastic lesions in bladder as predominating effect (transitional cell papilloma, 44% (p≤0.05); transitional cell carcinoma 56% (p≤0.01). " ;
        ont:description_pod        "noael mg/kg bw/d" ;
        ont:gross_pathology        "liver: increases in liver weight; changes in liver enzymes. increase in kidney weights." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "there was a tendency towards anaemia in females at 0.5% and above," ;
        ont:histopathology         "in the urinary bladder of males 1 papilloma was found at 1%, 4 papillomas plus 5 transitional cell carcinomas at 2% and 1 transitional cell carcinoma at 4%, as opposed to only 2 papillomas at 4% in females. no bladder calculi were observed. moderate pyelonephritis was recorded in 6/10 males and slight in 1/10 females at 4%. no tumours at sites other than the urinary system were found. kidneys: pyelonephritis in high dose males and females; " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "Survival was 90 %, 90 %, 95%, 90 %, 90 %, 57 % and 70 % in rats fed 0, 62, 125, 250, 500, 1000 and 2000 mg/kg bw/d " ;
        ont:point_of_departure     "353" ;
        ont:purity                 ">95" ;
        ont:species_strain         "rat/f344" ;
        ont:target_organ           "kidney, liver, urinary bladder" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "urinary pH (at week 13) tended to be alkaline with increasing dietary concentration." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/46>
        a                          ont:Test ;
        ont:clinical_observations  "in females, growth depression was marked at 50 ppm. dietary concentrations of 2, 5 and 10 ppm appeared to have an accelerating effect on weight gain in both sexes, and males showed a comparable stimulation at 25 ppm. the no effect level for males and females was 10 ppm (0.5 mg/kg/day). in males the highest level caused hind-limb paralysis in some animals." ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:critical_effect        "hind-limb paralysis, paralysis preceding death, higher mortality rate,  increase in neutrophil versus lymphocyte counts" ;
        ont:description_pod        "noael mg/kg/d" ;
        ont:gross_pathology        "ratios of organ weights to body weights did not differ significantly among the surviving groups at termination." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "the only unusual finding upon termination of the study was an increase in neutrophil versus lymphocyte counts in males on the 50 ppm diet." ;
        ont:histopathology         "histopathologic examinations did not reveal any lesions that appeared to be attributable to the administration of zpt. these observations included careful attention to retina, optic nerve, cerebral cortex, and other parts of the central and peripheral nervous systems. there were no significant differences in the rate of frequency of neoplasms between any of the groups. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "none of the females on the 50 ppm diet lived beyond 80 weeks. death was commonly preceded by paralysis. mortality was also increased at 25 ppm, and paralysis occurred in some animals prior to death." ;
        ont:point_of_departure     "0.5" ;
        ont:species_strain         "rat/wistar" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/25>
        a                       ont:Test ;
        ont:compound            <http://toxin.vub.be/resource/compound/vitamin%20a> ;
        ont:conclusion          "toxicity appears to occur when the amount of vitamin a in plasma exceeds the capacity of retinol binding proteins, leading to a change in the ratio of free retinol to retinol-rbp complexes" ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations  "teratogenic potential, effects on bone" ;
        ont:species_strain      "mouse, rats, rabbits, dogs, guinea pigs, cattle, chicken, pigs, ducks, hamsters, monkeys, sheep, cats" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/dossier/2%2C7-naphthalenediol>
        a              ont:Report ;
        rdfs:label     "2,7-naphthalenediol" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/67> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_034.pdf> .

<http://toxin.vub.be/resource/dossier/phenoxyethanol>
        a              ont:Report ;
        rdfs:label     "phenoxyethanol" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/24> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/1> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_195.pdf> .

<http://toxin.vub.be/resource/dossier/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate>
        a              ont:Report ;
        rdfs:label     "o-phenylphenol, sodium o-phenylphenate and potassium o-phenylphenate" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/106> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/119> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/107> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/108> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/122> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/110> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/109> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/123> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/112> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/115> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/111> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/116> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/113> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/104> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/114> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/117> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/105> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/118> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/102> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/120> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/103> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/121> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/OECD%20TG%20453> , <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_177.pdf> .

<http://toxin.vub.be/resource/compound/zinc%20pyrithione>
        a               ont:Compound ;
        rdfs:label      "zinc pyrithione" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/zinc%20pyrithione> .

<http://toxin.vub.be/resource/dossier/boron%20compounds>
        a              ont:Report ;
        rdfs:label     "boron compounds" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/136> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_027.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/96>
        a                          ont:Test ;
        ont:additional_info        "test substance: HC Yellow n°4" ;
        ont:chemical_batch_nr      "Lot 0-218" ;
        ont:clinical_observations  "rats: all animals survived to the end of the studies. the final mean body weights and mean body weight changes of males that received doses of 20000 ppm and above and females that received doses of 10000 ppm and above were significantly lower than those of controls. feed consumption by males that received doses of 20000 ppm or greater and females that received doses of 10000 ppm or greater was lower than that of the controls during the first week. during the second week, feed consumption by males in the 40000 ppm dose group was lower than controls; feed consumption by other male and female dose groups was similar to or higher than that of the control. because rats that received 40000 ppm did not gain weight, and the final mean body weights of rats that received 80000 ppm were decreased approximately 30 %, it was concluded that the feed consumption values were high and may have included feed scattered by animals searching for non-dosed food. no clinical findings were attributed to hc yellow n°4 administration. mice: all mice survived to the end of the studies. the final mean body weights and mean body weight changes of females and the mean body weight changes of males that received doses of 20000 ppm were significantly lower than those of controls. final mean body weights and mean body weight changes of other dose groups were similar to those of the controls. feed consumption by dosed groups was generally similar to that of the controls during the first week. during the second week, feed consumption by males and females in the 10000 and 20000 ppm dose groups was higher than controls. no clinical findings in mice were related to hc yellow n° 4 administration." ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:conclusion             "in the 14-day rat feed studies, doses of 20000 ppm (males) or 10000 ppm (females) and above caused decreases in body weight and feed intake. in the 14-day mouse feed studies, doses of 1250 to 20000 ppm (equivalent to 150 to 3200 mg/kg) caused no toxic effects." ;
        ont:gross_pathology        "rat: significant changes in absolute and relative organ weights were observed but were considered to be secondary to decreases in body weights. mouse:   no biologically significant changes in absolute and relative organ weights were observed. no gross or microscopic lesions were related to hc yellow n° 4 administration." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                 "> 93" ;
        ont:species_strain         "rat/f344/n; mouse/b6c3f1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/131>
        a                          ont:Test ;
        ont:clinical_observations  "there were no significant differences in body weight of any dosed group to the control group. feed consumption: there were no significant differences of any dosed group to the control group. observations in life: bedding material of all animals dosed with 1000 mg/kg bw/day was stained bright brown, resembling the colour of the test substance. this is most likely due to urinary excretion of the test substance and/or its metabolites. these stains are not regarded as toxic changes. some of the animals of the highest dosed group (1000 mg/kg bw/day) suffered from transient apathy, starting about 30 min after test substance administration and lasting for about another 30 min. this is regarded to be a toxic change.  " ;
        ont:composition            "test substance dissolved in distilled water (doses of 100mg/kg and less) suspended in a 0.5% aqueous cmc (doses of 316, and more)" ;
        ont:compound               <http://toxin.vub.be/resource/compound/2%2C6-dihydroxyethylaminotoluene> ;
        ont:conclusion             "the dose of 316 mg/kg bw represents the no-adverse-effect-level for both sexes, where no significant differences to the control group were found. test compound-related alterations in the highest dosed group (1000 mg/kg bw) were of only low severity. therefore, a dose of 1000 mg per kg bw/d may be used as the high dose in the main study whereas 100 and ca. 300 mg per kg bw/d may serve as low- and mid-dose, respectively. " ;
        ont:gross_pathology        "necropsy findings: a few single findings are altogether interpreted as incidental without test substance relationship" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:homogeneity_stability  "freshly dissolved in disilled water" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:physical_form          "liquid" ;
        ont:species_strain         "rat/Wistar" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/75>
        a                          ont:Test ;
        ont:additional_info        "test substance : bmhca" ;
        ont:clinical_observations  "slight decrease in body weights and marked testicular atrophy were noted at 2000 mg/kg bw/day. some effects on seminiferous tubules, decreases of the number of germ cells, and increases of the number of degenerating germ cells (including giant cells) were observed in combination with degenerating germ cells in epididymides and the occurrence of spermatocele at the highest dose tested." ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:gross_pathology        "no clinical signs or substance-related necropsy findings were observed. no further observations were performed in this study to assess adverse effects other than testicular toxicity." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                 "99.1" ;
        ont:species_strain         "rat" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/110>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "investigation of bladder by LM and SEM; 12- and 48 week urines analysed for volume, osmolality, pH, microscopy. morphological changes in bladder only remarkable in rats; reduced body weight gain in rats, mice: growth retarded from week 8. guinea pig: retardation of body weight after week 8." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "rats: simple epithelial and pleomorphic microvilli at each time point, pn ( papillary or nodular) hyperplasia in weeks 36 and 48; slightly increased urinary pH values and crystal formation after 12 and 48 weeks.guinea pig: slight crystal formation after 12 and 48 weeks; no bladder changes. mouse: no effects on urinary parameters or bladder." ;
        ont:species_strain         "rat/f344; mouse/b6c3f1; hamster/syrian golden; guinea pig/hartley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/2>
        a                           ont:Test ;
        ont:additional_info         "test substance: hydroxypropyl p-phenylenediamine HCl" ;
        ont:blood_serum_biomarkers  "an increase in the level of triglycerides was observed in female rats treated with the dose 100 mg/kg/day." ;
        ont:chemical_batch_nr       "r0025521b 004 p 001" ;
        ont:clinical_observations   "rats in the mid dose group (300 mg/kg) showed significant reductions in body weight gain compared to controls, from day 4 onwards in males and from day 8 onwards in females. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/hydroxypropyl%20p-phenylenediamine%20and%20its%20dihydrochloride%20salt> ;
        ont:conclusion              "the dose level of 300 mg/kg can be considered a maximum tolerated dose" ;
        ont:critical_effect         "decrease in red blood cell count, hematocrit and prothrombin time, increase in platelet counts, increase of relative liver  and kindey weight" ;
        ont:description_pod         "noael, mg/kg/day" ;
        ont:gross_pathology         "an increase in relative weight of liver (relative to terminal body weight)  was observed in female rats treated with the dose 100 mg/kg/day." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "mortality was observed in the high and mid dose groups (10/10 and 1/10, respectively)" ;
        ont:point_of_departure      "100" ;
        ont:purity                  "98.6" ;
        ont:species_strain          "rat /wistar" ;
        ont:target_organ            "liver, haematopoietic system, kidney" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "yellow to yellowish brown colored urine was also observed, confirming the systemic exposure to hydroxypropyl p-phenylenediamine HCl. " .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/54>
        a                       ont:Test ;
        ont:additional_info     "test substance : nta" ;
        ont:composition         "solution of granular detergent containing  nta" ;
        ont:compound            <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration       "11; 10" ;
        ont:conclusion          " no indication for systemic effects was observed. however, systemic bioavailability of nta is considered to be questionable, the data reported were incompliant to standard test design and therefore a n(l)oael for systemic toxicity cannot be derived. " ;
        ont:description_pod     "noael for local effect % 50 mg/kg bw/day" ;
        ont:gross_pathology     "no treatment associated change was registered in any of the 15 internal organs examined." ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:histopathology      "microscopic examination revealed that animals treated with the 10% and 11% nta solutions showed only mild skin irritation." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:physical_form       "liquid" ;
        ont:point_of_departure  "2.5" ;
        ont:species_strain      "rabbit/albino" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/33>
        a                           ont:Test ;
        ont:additional_info         "test substance: zinc omadine win 9546" ;
        ont:blood_serum_biomarkers  "no toxicologically significant findings were noted following clinical chemistry" ;
        ont:chemical_batch_nr       "97-p-158, rn no. 7-72-3 " ;
        ont:clinical_observations   "no clinical signs of toxicity were reported.electrocardiograms of the high dose group were essentially normal. no skeletal muscle samples were examined. no clinical signs of toxicity were reported." ;
        ont:composition             "suspension of the test substance in the vehicle" ;
        ont:compound                <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:description_pod         "loael mg/kg/d, noael mg/kg/d " ;
        ont:gross_pathology         "relative kidney weights in the intermediate and high dose were reduced compared to control, which was attributed to high kidney weights in the control animals. relative uterus weight was reduced in a dose-related manner at 2.0 and 8.0 mg/kg/d and was associated with apparent immaturity of the uteri." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "no toxicologically significant findings were noted following haematological" ;
        ont:histopathology          "no abnormal findings were noted following gross and histopathological examination." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:physical_form           "liquid" ;
        ont:point_of_departure      "2, 0.5" ;
        ont:species_strain          "monkey/ rhesus" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "no toxicologically significant findings were noted following urinalysis" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/12>
        a                          ont:Test ;
        ont:additional_info        "test substance: hc red n° 3" ;
        ont:chemical_batch_nr      "lot 5890377" ;
        ont:clinical_observations  "rat: the final mean body weights of males that received doses of 1000 mg/kg bw/d and 500 mg/kg bw/d were respectively 7% and 5% lower than those of controls. final body weights of dosed female were greater than those of controls; mouse: the final mean body weights of males that received doses of 250 mg/kg bw/d were 7% lower than those of controls. final body weights of dosed female were comparable to those of controls." ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20red%20n°%203> ;
        ont:conclusion             "pigmentation was not considered by the applicant as adverse effects and based on the body weight decrease observed at 1000 mg/kg bw/d and 500 mg/kg bw/d, the noael is 250 mg/kg bw/d in rats while the noel is 125 mg/kg bw/d (adjusted for 5 days treatment per week: 180 and 90 mg/kg bw, respectively). in mice, based on the body weight decrease observed at 250 mg/kg bw/d the noael is 125 mg/kg bw/d (adjusted to 90 mg/kg bw). " ;
        ont:critical_effect        "body weight decrease" ;
        ont:description_pod        "noael mg/kg bw/d in rat; noael mg/kg bw/d in mouse" ;
        ont:gross_pathology        "mouse :no compound-related microscopic pathologic effects were recorded." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "rat: granules of brown to golden-brown pigment were found in the cytoplasm of the thyroid gland follicular epithelial cells in 10/10 males and 10/10 females that received 1000 mg/kg bw/d and in 10/10 males and 7/10 females that received 500 mg/kg bw but not in any of the rats that received 250 mg/kg bw/d. similar pigment was found in the cytoplasm of convoluted tubular epithelial cells in the kidneys of all rats that received 1000 mg/kg bw/d and in 7/10 males and 10/10 females that received 500 mg/kg bw and in 6/10 males and 7/10 females that received 250 mg/kg/d; mouse :no compound-related microscopic pathologic effects were recorded." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "0 in rats, in mice all death occured were related to gavage technique" ;
        ont:point_of_departure     "250; 125" ;
        ont:purity                 "97" ;
        ont:species_strain         "rat / f344/n; mouse / b6c3f1" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "rat: the urine of all dosed animals was orange to purple throughout the studies; mouse: the urine of all dosed animals was red throughout the studies." .

<http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29>
        a               ont:Compound ;
        rdfs:label      "butylphenyl methylpropional (p-bmhca)" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/butylphenyl%20methylpropional%20%28p-bmhca%29> .

<http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29>
        a               ont:Compound ;
        rdfs:label      "n-methyl-2-pyrrolidone (NMP)" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/n-methyl-2-pyrrolidone%20%28NMP%29> .

<http://toxin.vub.be/resource/dossier/toluene-2%2C5-diamine%20and%20its%20sulfate>
        a              ont:Report ;
        rdfs:label     "toluene-2,5-diamine and its sulfate" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/59> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_052.pdf> .

<http://toxin.vub.be/resource/compound/Acid%20black%201>
        a               ont:Compound ;
        rdfs:label      "Acid black 1" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/Acid%20black%201> .

<http://toxin.vub.be/resource/compound/resorcinol>
        a               ont:Compound ;
        rdfs:label      "resorcinol" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/resorcinol> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/139>
        a                    ont:Test ;
        ont:additional_info  "test substance: d5" ;
        ont:compound         <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:conclusion       "no test article-related effects on survival, clinical condition, body weights, body weight gains, food consumption or ophthalmoscopy at any exposure level were observed in this study. no test article-related gross findings were observed. at the week 6-recovery necropsy, no effects on liver weights were observed. " ;
        ont:gross_pathology  "a significant increase in mean lung weight (15%) and alveolar macrophage accumulation was observed in the 160-ppm group. treatment-related morphological alterations (goblet cell proliferation) were also noted in the nasal cavity of both sexes at concentration of 10 ppm of d5 or greater. these changes were reversible following a two-week recovery period. males (75 ppm) and females (160 ppm) were noted as having increased incidence and severity of submucosal inflammation in the lung, which were reversible after the recovery period. the mean (absolute and relative) liver weights in the 160 ppm group, especially the females, were increased at the week 4 primary necropsy." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:histopathology   "no histopathological changes were noted" ;
        ont:species_strain   "rat/fischer 344" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/83>
        a                          ont:Test ;
        ont:additional_info        "test substance: p-aminophenol" ;
        ont:clinical_observations  "significant decrease in body weight gain was observed at 467 mg/kg bw/day as in the three month study; the males that had been allowed a reversibility period also had decreased body weight gain" ;
        ont:compound               <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:gross_pathology        "increased relative liver, kidney, and brain weights were attributed to compound administration; these changes were not observed in rats allowed a reversibility period" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "nephrosis, characterized by eosinophilic droplets in renal tubules, was diagnosed in both sexes at 467 mg/kg bw/day (including recovery males). the severity of this finding was dose-dependent" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations     "there were no significant clinical pathology changes." ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/118>
        a                          ont:Test ;
        ont:additional_info        "test substance: OPP" ;
        ont:chemical_batch_nr      "#8800005-24" ;
        ont:clinical_observations  "there were no effects on body weight, feed consumption, ophthalmology, haematology, urinalysis, and pathology. the only clinical sign was vomiting (dose-dependent increase)" ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:description_pod        "NOAEL mg/kg bw/d" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:point_of_departure     "> 300" ;
        ont:purity                 "99.77" ;
        ont:species_strain         "dog/Beagle" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/62>
        a                           ont:Test ;
        ont:additional_info         "test substance: sodium perborate tetrahydrate" ;
        ont:blood_serum_biomarkers  "there were no statistically significant differences compared to controls blood parameters (all relevant parameters investigated, figures included in the report)" ;
        ont:clinical_observations   "there were no statistically significant differences compared to controls in growth, organ/body weight ratios (liver, kidney)," ;
        ont:composition             "aqueous solution" ;
        ont:compound                <http://toxin.vub.be/resource/compound/sodium%20perborate%20%28tetrahydrate%29> ;
        ont:concentration           "liquid" ;
        ont:gross_pathology         "there were no statistically significant differences compared to controls in organ/body weight ratios (liver, kidney),there were no statistically significant differences compared to controls in  gross pathology" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "there were no statistically significant differences compared to controls blood parameters (all relevant parameters investigated, figures included in the report)" ;
        ont:histopathology          "there were no statistically significant differences compared to controls in histopathology (organs required in current guidelines investigated)" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:pH_adjustment           "10" ;
        ont:species_strain          "rabbits/new zealand white" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/dossier/2%2C6-dihydroxyethylaminotoluene>
        a              ont:Report ;
        rdfs:label     "2,6-dihydroxyethylaminotoluene" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/131> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_188.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/41>
        a                           ont:Test ;
        ont:additional_info         "test substance: zinc omadine ® fps" ;
        ont:blood_serum_biomarkers  "statistically significantly increased cholesterol levels were determind in high dose females." ;
        ont:chemical_batch_nr       "33-22902781" ;
        ont:clinical_observations   "there were signs of irritation such as red foci and desquamation in one male and one female animal at the highest dose. mean body weights of the 1000 mg/kg males were lower compared to controls during the first four weeks of the study, thereafter they were higher than in controls. in females, mean body weights at 1000 mg/kg/d were lower (17.4% at study termination) than control with statistically significant difference from week 2; correspondingly, food consumption was lower in high dose females. no test-item related ophthalmoscopic abnormalities were observed." ;
        ont:composition             "zinc 2-pyridinethiol-n-oxide (cas 13463-41-7; sodium naphthalenesulfonic acid (cas 9084-06-4-9) and water (cas 7732-18-5)" ;
        ont:compound                <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion              "noael calculated based on a decreased body weight in top dose females and on haematological changes the top dose, a noael of 100 mg/kg bw/d is derived from this study. " ;
        ont:critical_effect         "body weight depression, food consumption depression,haematological changes (increased leucocyte, decresed erythrocyte and haematocrit, increased cholesterol)" ;
        ont:description_pod         "noael mg/kg bw/day" ;
        ont:gross_pathology         "no toxicologically significant macroscopical findings was observed" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "in animals receiving 1000 mg/kg/d, statistically significantly increased leucocyte counts were found in males, statistically significantly depressed erythrocyte counts and haematocrit levels were found in females." ;
        ont:histopathology          "no toxicologically significant histopathological findings was observed" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "100" ;
        ont:purity                  "52.2" ;
        ont:species_strain          "rat/sprague-dawley" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/dossier/hc%20red%20n°%203>
        a              ont:Report ;
        rdfs:label     "hc red n° 3" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/14> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/13> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/12> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/11> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_043.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/20>
        a                           ont:Test ;
        ont:additional_info         "test substance: dehyquart a-ca" ;
        ont:blood_serum_biomarkers  "300 mg/kg bw/day: - minor increase in serum alt activity in males and females (within the range of the historical controls);" ;
        ont:chemical_batch_nr       "548050" ;
        ont:clinical_observations   "all animals survived the study and all treatment-related changes were shown to be reversible following the recovery period. there were no effects on food consumption and body weight development. the mean water intake of the males of the high dose group was higher than that of controls. ophthalmologic results revealed no treatment-related changes in any group." ;
        ont:composition             "cetrimonium in water" ;
        ont:compound                <http://toxin.vub.be/resource/compound/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride> ;
        ont:concentration           "24-26" ;
        ont:conclusion              "the study authors conclude that the forestomach and stomach changes observed at 300 mg/kg bw/day can be considered to be a result of local irritation and therefore are not indicative of systemic toxicity. the slight weight changes of spleen and adrenals and the increase in serum alt activity were regarded as a possible sign of some systemic toxicity. the dosage of 100 mg/kg bw/day was considered to be the no-observed-effect-level (noel) of dehyquart a-ca (24-26% cetrimonium chloride in water) in this study" ;
        ont:critical_effect         "weight changes of spleen and adrenals and the increase in serum alt activity" ;
        ont:description_pod         "noel, mg/kg bw/d" ;
        ont:gross_pathology         "at 300mg/kg bw/d in males: slight increase in absolute and relative adrenal weights and slight decrease in absolute and relative spleen weight" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "haematological results revealed no treatment-related changes in any group." ;
        ont:histopathology          "300 mg/kg bw/d : macroscopic examination: thickening of the forestomach mucosa, associated with oedema and sporadic ulceration in male and female rats; - microscopic examination: inflammatory oedema of the forestomach mucosa, sporadic ulceration and acanthosis up to papillomatous hyperplasia in both sexes; - no histopathological alterations were found in adrenals and spleen or any other organs" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "100" ;
        ont:species_strain          "rat/sprague dawley" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/dossier/trisodium%20nitrilotriacetate>
        a              ont:Report ;
        rdfs:label     "trisodium nitrilotriacetate" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/56> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/51> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/53> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/49> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/57> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/54> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/50> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/52> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/58> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/55> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_046.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/91>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "at 1000mg/m3: after 10 days of exposure, the relative and absolute number of neutrophils was increased, while the number of lymphocytes was decreased. they returned to normal values after 2 weeks of recovery. at 100 and 500 mg/m³: there were no changes in body weight, blood and urinary analysis, and no pathological lesions after 4 weeks of exposure or 2 weeks post-exposure. " ;
        ont:clinical_observations   "at all levels, all rats showed signs of lethargy and irregular respiration after approximately 3-4 hr of exposure. these signs persisted until the end of exposure. rats at 100 and 500 mg/m³ recovered within 30-45 minutes post-exposure, but only a few rats recovered by 18 hr post-exposure at the high dose. because of the respiratory difficulty and of the mortality, exposure was discontinued after 10 days and the surviving rats were allowed to recover for 2 weeks. a decrease in weight gain was found after 5 days of exposure. at 100 and 500 mg/m³: there were no changes in body weight, blood and urinary analysis, and no pathological lesions after 4 weeks of exposure or 2 weeks post-exposure. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "histopathological examination of dead animals revealed focal pneumonia, hypoplasia and haemorrhage in the bone marrow, and atrophy of the lymphoid tissue in the spleen and thymus" ;
        ont:homogeneity_stability   "aerosol-vapour mixture" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "at 1000 mg/m³: out of 30 rats, 8 rats died and 5 rats were euthanised within the first 9 days of exposure. " ;
        ont:particle_size_and_procedure
                "> 95 % of the droplets below 10 µm in diameter" ;
        ont:purity                  "100" ;
        ont:species_strain          "rat/crl:cd" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/126>
        a                           ont:Test ;
        ont:additional_info         "test substance: C-1701 B_C_3" ;
        ont:blood_serum_biomarkers  "no toxicologically relevant test item-related changes in  clinical chemistry  parameters was observed." ;
        ont:chemical_batch_nr       "1442/3+4" ;
        ont:clinical_observations   "treatment of male rats with the test item resulted in clinical signs (discoloured fur, mild to moderate dehydration, mild to moderate excess salivation, hunched posture, rales, decreased motor activity, swelling in the axillary region and ptosis), reductions in body weight gain and food consumption, and increased liver weights at the high-dose level of 1000 mg/kg bw/day. females at the same dose level showed clinical signs (discoloured fur, mild dehydration, urine-stained abdominal fur and chromorhinorrhea) and increased liver weights. increased liver weights were also seen in females treated at 300 mg/kg bw/day. in the absence of concomitant macroscopical and histopathological findings, the increased liver weights noted in both sexes at 1000 mg/kg bw/day and in females also at 300 mg/kg bw/day were not considered adverse. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/Methoxypropylamino%20Cyclohexenylidene%20Ethoxyethylcyanoacetate%20%28S87%29> ;
        ont:conclusion              "the noael for c-1701 b_c_3 was established at 300 mg/kg bw/day for male and female rats. dose levels of 100, 300 and 1000 mg/kg bw/day were selected for the subsequent 90-day repeated dose oral toxicity study in rats" ;
        ont:description_pod         "NOAEL, mg/kg bw/d" ;
        ont:gross_pathology         "except for the liver, no relevant test item-related changes in organ weights were noted on the day of scheduled necropsy. macroscopical and histopathological examinations revealed no adverse test item-related gross lesions or microscopic findings in both male and female rats." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "no toxicologically relevant test item-related changes in haematology parameters was observed." ;
        ont:histopathology          "macroscopical and histopathological examinations revealed no adverse test item-related gross lesions or microscopic findings in both male and female rats." ;
        ont:homogeneity_stability   "the dose formulations used in this study were analysed for test item concentration and homogeneity. stability analyses demonstrated that the test item is stable in peg 300 at room temperature and protected from light for 24 hours and under refrigerated conditions (2-8 °C) and protected from light for 10 days at concentrations bracketing those used in the present study. all dose formulations used in this study were formulated appropriately and remained within the concentration acceptance criterion (i.e., difference between analytically determined mean concentration and nominal concentration ≤ 15%). homogeneity testing showed that the formulation technique used produced homogenous dose formulations. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "300" ;
        ont:purity                  "98.8" ;
        ont:species_strain          "rat/Grl:Wi (Han)" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "no toxicologically relevant test item-related changes in urinalysis parameters was observed." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/70>
        a                    ont:Test ;
        ont:additional_info  "test substance : bmhca" ;
        ont:compound         <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:conclusion       "there was no effect on any of the parameters investigated, including testes or epididymides" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "mouse" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/105>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "36 treated and 11 control rats investigated." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration          "2" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "findings in urinary bladder: papillary/nodular hyperplasia in 86% treated rats vs 0% in controls (p≤0.01); papilloma in 54% treated rats vs 0% in controls (p≤0.01); carcinoma in 39% treated rats vs 0% in controls (p≤0.05)." ;
        ont:species_strain         "rat/f344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/49>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "high doses male and female showed a tendency to higher urea concentrations but no clear effect on creatinine levels was seen." ;
        ont:clinical_observations   "lower feed consumption was observed in high dose males from day 7 to the end of the study and in high dose females only at day 7. a dose-related lower body weight and lower body weight gain were observed in treated males gaining significance at the mid and high dose levels. in the mid and high dose females a transient reduction of the body weight and body weight gain was observed on day 7 of the study. diarrhoea, anogenital region smeared with urine, crust formation at the nose and piloerection were observed in high dose males and females." ;
        ont:compound                <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:conclusion              "no adverse effect was observed at the dose of 150 mg/kg H3NTA (noael)." ;
        ont:description_pod         "noael mg/kg bw/d" ;
        ont:gross_pathology         "the mean values of absolute kidney weights were significantly higher in high dose females compared to the control group. significantly elevated relative kidney weights were found in high dose males and females of the mid and high dose groups. enlarged and discoloured kidneys were observed in each one male and female of the mid and high dose groups." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "a white focus was noted in one kidney of a high dose male, the lesion was confirmed to be an area of severe tubular hyperplasia. light microscopy of the kidneys revealed tubular vacuolation, often multifocal and bilateral, in most males and females of the mid and high dose groups. males were more affected than females, and the mean severity of this lesion increased with dosage. a focal degeneration of the pars recta was observed in one high dose female. the incidence of low graded basophilic (regenerating) tubules was similar between treatment and control groups, whereas the incidence of this lesion with higher severity grades increased with dosage. in addition to the focus in one high dose male confirmed to be an area of severe tubular hyperplasia, another lesion of the tubules was ,noted in a second high dose male. this lesion consisted of hyperplastic basophilic and clear cell tubules. futher findings as mononuclear cell infiltration, interstitial fibrosis, proteinaceous casts, focal glomerulopathy and calcification at the cortico-medullary junction were similarly distributed between the treatment and control groups. ultrastructural examinations did not show alterations of the pars recta of the proximal tubule in animals of the low and mid dose groups. a prominent vacuolation of tubular cytoplasm of a high dose male was characterised as a vacuolation and vesiculation of the rough endoplasmatic reticulum due to increased water influx. roundish, sometimes irregular shaped vacuoles were observed in the cells of the third segment of the proximal tubule. electron-lucent vacuoles of different sizes were regularly distributed in the cytoplasm and were limited by a singular membrane. electron-dense structures with a diameter of 10 nm identical to the morphology of ribosomes were free or in close contact to the vascuolar membranes. vacuolated cells appeared to have fewer cell organelles such as mitochondria and lysosomes, the content of strands of the rough endoplasmatic reticulum was markedly reduced. the observed vacuolar degeneration was regarded a consequence of acute cellular swelling which finally results in cell death. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "92" ;
        ont:purity                  "98-99" ;
        ont:species_strain          "rat/wistar" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "urinalysis revealed non-significantly lower pH values in males in a dose-related manner and in high dose females. increased blood and erythrocytes were detected in the urine specimens of high dose males, whereas increased renal tubular and transitional epithelial cells and granular casts were observed in the urine of the high dose females. " .

<http://toxin.vub.be/resource/dossier/butylphenyl%20methylpropional%20%28p-bmhca%29>
        a              ont:Report ;
        rdfs:label     "butylphenyl methylpropional (p-bmhca)" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/76> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/70> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/72> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/78> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/75> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/71> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/68> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/77> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/73> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/69> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/74> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_213.pdf> , <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_189.pdf> .

<http://toxin.vub.be/resource/dossier/zinc%20pyrithione>
        a              ont:Report ;
        rdfs:label     "zinc pyrithione" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/41> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/38> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/35> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/42> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/39> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/36> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/43> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/37> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/44> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/40> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/45> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/46> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/47> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/31> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/48> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/32> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/33> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/34> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_133.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/28>
        a                       ont:Test ;
        ont:compound            <http://toxin.vub.be/resource/compound/vitamin%20a> ;
        ont:conclusion          "middle aged and elderly women were the group most sensitive to such effects.  it was not known however, whether the same dose-response relationship would apply in men or in children. based on epidemiological data, no association has been found in the majority of case control studies between daily doses of vitamin a of 3000 mg retinol equivalence or less and foetal malformation. however, in each of these studies, the number of women consuming high amounts of vitamin a was too limited to give a reliable estimate of a safe intake value. " ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:other_observations  "reduced bone density and increased rates of fracture" ;
        ont:species_strain      "human" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/compound/acid%20red%2092>
        a               ont:Compound ;
        rdfs:label      "acid red 92" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/acid%20red%2092> .

<http://toxin.vub.be/resource/dossier/sodium%20perborate>
        a              ont:Report ;
        rdfs:label     "sodium perborate" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/61> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_031.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/99>
        a                           ont:Test ;
        ont:additional_info         "test substance: HC Yellow n°4" ;
        ont:blood_serum_biomarkers  "a statisically significant increase in blood urea nitrogen in males and females was reported." ;
        ont:clinical_observations   "no evidence of compound-induced toxicity was seen. body weight gain of rabbits was at least equal to that of controls.  ." ;
        ont:composition             "HC Yellow n° 4 in hair dye formulation" ;
        ont:compound                <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:concentration           "0.4" ;
        ont:conclusion              "there was no evidence of hc yellow n°4-induced systemic effects" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "a statisically significant increase in white blood cells in males and in blood urea nitrogen in males and females was reported." ;
        ont:histopathology          "microscopic examinations of 25 tissues from each animal gave no indication of histomorphologic evidence of toxicity" ;
        ont:species_strain          "rabbit/new zealand white" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "no dye discoloration of the urine was seen during the test." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/134>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "there were no treatment-related biochemical changes." ;
        ont:clinical_observations   "study showed no toxicity except for dermal irritation at the highest dose tested. upper respiratory disease during the study up to day 25. diarrhoea in all animals was not attributed to the test substance. dermal irritation (dermatitis) was observed at the high dose and was dose-dependent." ;
        ont:composition             "12.5% triclosan added to 50% corn-starch vehicle" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion              "test substance was reported to show “little toxic effect” aside from dermal irritation (pathology data not reported)." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "there were no treatment-related  haematological changes." ;
        ont:histopathology          "microscopic examination revealed no histomorphology changes in the skin." ;
        ont:species_strain          "dog/Beagle weanling" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/5>
        a                           ont:Test ;
        ont:additional_info         "test substance: triclosan" ;
        ont:blood_serum_biomarkers  "in the remaining animals, alterations in serum chemistry such as glutamic-pyruvic transaminase, alkaline phosphatase were observed. " ;
        ont:clinical_observations   "following the first day, due to the occurrence of deaths, dyspnoea and general clinical signs indicative of poor health in the treated animals, the test concentrations were reduced to 0, 50, 115, or 301 mg/m3 for dosing on days 2-15, i.e., the remainder of the study." ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion              "the noael for inhaled triclosan was determined to be the lowest dose tested." ;
        ont:description_pod         "noael mg/m3" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "in the remaining animals, dose-related increases in leukocyte count" ;
        ont:histopathology          "slight focal inflammation of the mucous membranes was observed in high-dose animals at the end of the study" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "although there were 12 unscheduled deaths related to high-dose level exposure, 11 of the 12 rats died during day 1 as a result of the very high initial doses. necropsy revealed congestion, inflammatory changes in mucous membranes and nasal cavity." ;
        ont:point_of_departure      "50" ;
        ont:species_strain          "rat" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/78>
        a                   ont:Test ;
        ont:compound        <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:conclusion      "confirmed the known potential of p-bmhca" ;
        ont:guideline       <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel  "non OECD" ;
        ont:species_strain  "rat" ;
        ont:type            "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/113>
        a                          ont:Test ;
        ont:additional_info        "test substance: OPP, technical grade" ;
        ont:chemical_batch_nr      "S-01-93" ;
        ont:clinical_observations  "mean body weights were decreased in mid- and high-dose males and females, while food consumption remained unchanged. ophthalmology, haematology, and clinical chemistry were not remarkable. a 5% decline in body weight gain was noted in 4000 ppm males and females while 11% declines were seen in males and females of the highest dose tested.  supplemental data submitted by the registrant to calepa indicated that there were problems in the reporting of the various evaluations that pertain to the eyes and optic nerves (ophthalmology, clinical observations, necropsy, and histology) for this study. since OPP and its metabolites are chemically similar to the metabolites of Naphthalene, which are responsible for its cataractogenic activity (gehring, 1971, wells et al., 1989), potential injury to the vision system attributable to OPP administration in both sexes should not be dismissed without further investigation. although the elevated cardiac incidence did not occur in the high-dose females, this group showed reductions in feed consumption and body weight gain and feed restriction/body weight reduction is known to reduce the incidence and severity of cardiac fibrosis in both sexes of f344 rats (imai et al., 1991)." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion             "with respect to the heart effects in females, CalEPA derived a LOAEL of 49 mg/kg bw/d from this study" ;
        ont:description_pod        "noael mg/kg bw/d in males; in females" ;
        ont:gross_pathology        "postmortem findings in mid and/or high dose groups included wet/stained ventrum, urinary bladder masses, as well as pitted zones and abnormal texture in the kidney, essentially in the 2-year groups. " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/OECD%20TG%20453> ;
        ont:guidelineLabel         "OECD TG 453" ;
        ont:histopathology         "histopathology revealed increased incidences of - simple urinary bladder hyperplasia in 1 yr 8000 ppm males(100 % compared to 0 % in controls; p p<0.01), in 2 yr 4000 ppm males (12 % compared to 4 % in controls,not statistically significant), in 2 yr 8000 ppm males (84 % compared to 4 % in controls; p<0.01) and 12% (p<0.05) in 2 yr 10000 ppm females); - nodular/papillary urinary bladder hyperplasia in 1 yr 8000 ppm males (100 % vs 0 % in controls; p<0.01) and 2 yr 8000 ppm males (86% vs 1% in controls; p<0.01) and one case in 2 yr 10 000 ppm females; - urinary bladder calculi, congestion, haemorrhage, mineralisation and necrosis in 2 yr 8000 ppm males; - urinary bladder papilloma in 1 yr (30 % vs 0 % in controls; p<0.05) and 2 yr (12 % vs 0 % in controls; p<0.05) 8000 ppm males; - urinary bladder transitional cell carcinoma in 1 yr 8000 ppm males (15 % vs 0 % in controls) and 2 yr 4000 (4 % vs 0 % in controls) and 8000 ppm males (68 % vs 0 % in controls; p<0.01); - ureter dilatation and/or transitional cell hyperplasia in 2 yr 10000 ppm females; - calculi in the renal pelvis of 1 yr 8000 ppm males; - renal cystic tubular dilatation in 1 yr 10000 ppm females (incidence 25 %; p<0.05)and in 2 yr 8000 ppm males (incidence 34 %; p<0.05) and 10000 ppm females (incidence 74 %;p<0.05); - renal tubular hyperplasia in 1 yr and 2 yr 10000 ppm females (incidence 60 %;p<0.05%);  - renal infarct in 1 yr and 2 yr 10000 ppm females; - acute inflammation and dilatation of the renal pelvis in 2 yr 10000 ppm females ; - renal mineralisation in 2 yr 10000 ppm females. calepa (2007) discusses further aspects: a) eye effects: other organs that OPP affected were the eyes and heart. at ophthalmology, increased (p<0.05) incidence of cataract occurred in the terminal sacrifice males at 8000 ppm (61 % incidence vs. 36 % in the controls) and increased (p<0.05) incidences of cataract, uveitis,  and corneal vascularization occurred in the females at 4000 ppm (incidences of 27 %, 22 and 22 %, respectively; the respective incidence in the controls were 7 %, 4 %, and 2 %). the female histological data for the 4000 ppm group exhibited increased (p<0.05) incidences of retinal degeneration (27 % incidence vs. 7 % in the controls) and optic nerve atrophy (29 % incidence vs. 13 % in the controls). the incidences of these eye effects did not similarly increase in the 10000 ppm female group. b) cardiac effects: in the terminal sacrifice females, the incidences of cardiac degeneration and (or) fibrosis in both the controls and high-dose groups were comparable (54 % and 46 %, respectively). by contrast, the mid- and low-dose groups exhibited increased (p<0.05) incidences (84 % and 75 %, respectively). in the 2-year terminal sacrifice males, the incidences of vascular mineralisation involving the wall of the heart-base vessels in the 0, 800, 4000, and 8000 ppm groups were 2 %, 8 %, 22 % (p<0.05) and 11 %, respectively. " ;
        ont:homogeneity_stability  "4 analyses covering a period of 2.5 years, i.e. confirming stability. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "mortality was slightly increased in high-dose males." ;
        ont:point_of_departure     "39; 49" ;
        ont:purity                 "99.5 – 100" ;
        ont:species_strain         "rat/CDF[F-344]/BR" ;
        ont:target_organ           "kidney, urinary bladder, eyes, heart " ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "clinical observations at 4000 ppm and above included abnormal urine colour and various stains. urinalyses showed an increased incidence of blood in high-dose males." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/57>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "at 0.05% and 0.1% levels of nta blood glucose levels are significantly elevated above control values. blood urea nitrogen did not differ among any of the groups." ;
        ont:clinical_observations   "weight gain did not differ among any of the groups." ;
        ont:compound                <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration           "0, 0.01, 0.05, 0.1" ;
        ont:conclusion              "the noael for effects on blood level on glucose was 0.01% NTA (approx. 10 mg/kg bw/day)." ;
        ont:description_pod         "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:gross_pathology         "kidneys, ureters and urinary bladder" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "in the 0.1% nta group two rats died before the end of the ten-week period." ;
        ont:point_of_departure      "92" ;
        ont:species_strain          "rat/charles river cd sprague-dawley derived" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/36>
        a                   ont:Test ;
        ont:composition     "2 ml of water per gram of 50% wettable ZPT powder" ;
        ont:compound        <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:concentration   "50" ;
        ont:conclusion      "from the snyder et al (1965) study, one can conclude that a dose level of 10 mg/kg/day of zpt applied topically to rabbits is a no-effect level. interpretation of the rabbit studies by larson (1957) and nelson et al (1965) summarised here, is complicated by several factors. depending on what larson (1957) used to wash the animals, some material probably remained on the skin and was subsequently ingested. the nelson et al (1965) study, and the uncertainty regarding ingestion in these studies make any conclusions tentative, at best. that ingestion of zpt occurred in these studies can be supported by examining dose levels used in teratology studies conducted by nolen et al (1975, 1979). he reported that application of 25 to 100 mg/kg/day of zpt to the backs of rabbits produced no adverse effects when ingestion was meticulously prevented. therefore, 100 mg/kg/day instead of 10 mg/kg/day is a better estimate of a no-effect level for topical administration to rabbits. the no-effect level in mice for percutaneous toxicity is approximately 100 mg/kg/day, and the effect level (local irritation) is approximately 200 mg/kg/day. " ;
        ont:guideline       <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel  "non OECD" ;
        ont:histopathology  "four of twelve animals dosed at the lower levels survived, and those were necropsied at that time. focal necrosis of, either the brain or spinal cord in three of the four surviving animals. there were no histological changes in other organs." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate  "none of the rabbits receiving 1000 or 2000 mg/kg survived the 90-day test period, the longest survival being 21 days + 8 of the lower dose groups" ;
        ont:physical_form   "solid" ;
        ont:species_strain  "rabbit/albino" ;
        ont:type            "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/15>
        a                          ont:Test ;
        ont:additional_info        "test substance: acid orange 7" ;
        ont:chemical_batch_nr      "2097af, lot no. aj 3559" ;
        ont:clinical_observations  "discoloration of faeces resulting from the oral administration of acid orange 7 was observed. no changes were observed in the body and body weight gains of the rats, nor in the food consumption." ;
        ont:composition            "test substance in aqueous solution (bi-distilled water) + vehicle" ;
        ont:compound               <http://toxin.vub.be/resource/compound/acid%20orange%207> ;
        ont:conclusion             "on the basis of the results obtained in the 14-day dose range finding study, a proposal of dose levels for 90 day sub-chronic toxicity study is not possible. therefore, an additional 14- day range finding study with the dose levels of 0, 2.5, 5, 10 mg/kg bw/day was envisaged." ;
        ont:gross_pathology        "a significant increase in the absolute and relative spleen weight was observed in the rats treated at the doses of 60, 100, 300 and 1000 mg/kg bw/day. at 10 mg/kg bw/day this increase was also observed but was not statistically significant." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "enlarged spleens were macroscopically observed in all rats treated at the dose of 100, 300 and 1000 mg/kg bw/day. extramedullary hemopoiesis was observed in all rats treated at the dose of 10 and 60 mg/kg bw/day (no histological examination was performed on other groups). this was considered to be related to the tested compound. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                 "90" ;
        ont:species_strain         "rat / hanibm:wist spf" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/dossier/methylimidazoliumpropyl%20p-phenylenediamine%20HCl>
        a              ont:Report ;
        rdfs:label     "methylimidazoliumpropyl p-phenylenediamine HCl" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/79> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_231.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/142>
        a                          ont:Test ;
        ont:additional_info        "test substance: D5" ;
        ont:clinical_observations  "in this study, no effects were seen on body weight, body weight gain, food consumption, or clinical condition. there were no gross findings.  " ;
        ont:compound               <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:conclusion             "all effects were reversible during the 14-day recovery period. the NOAEL reported in this study was 0.081 mg D5/L air (5 ppm)." ;
        ont:description_pod        "mg D5/L air NOAEL (5 ppm)" ;
        ont:gross_pathology        "an increase in relative liver weight (percentage not stated) was also observed in male and female rats at 0.432 mg D5/l (28 ppm) and above." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "at 0.432 mg D5/l (28 ppm) and above, there was an increase in white blood cell and neutrophil counts (males only), a decreased number of red blood cells and mean corpuscular haemoglobin concentration. " ;
        ont:point_of_departure     "0.081" ;
        ont:species_strain         "rat/Wistar" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/86>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol" ;
        ont:composition      "three oxidative formulations of p-aminophenol" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "mouse/swiss webster" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/121>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "SOPP affected the kidneys and urinary bladder, as well as the pancreas; and the urinary bladder effects (both nonneoplastic neoplastic lesions) were more severe in the males than females, but the reverse is true for the kidney effects (nonneoplastic lesions only).the study was considered incomplete with respect to haematology and ophthalmology." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion             "based on increased incidences of focal atrophy of pancreatic acinar cells and interstitial nephritis in the females in the 2-week recovery study, the LOAEL was 5000 ppm (i.e., 224 mg/kg/day). the study was considered incomplete with respect to haematology and ophthalmology" ;
        ont:description_pod        "LOAEL ppm ( i.e. 224 mg/kg day)" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "in the 2-week recovery study, survivals in the control, low-dose, and high-dose groups at 104 weeks were 70 %, 88 %, and 20 % (p<0.01) in males and 84 %, 82 %, and 86 % in females." ;
        ont:point_of_departure     "5000" ;
        ont:purity                 "95.5" ;
        ont:species_strain         "rat/F344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/dossier/Methoxypropylamino%20Cyclohexenylidene%20Ethoxyethylcyanoacetate%20%28S87%29>
        a              ont:Report ;
        rdfs:label     "Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (S87)" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/126> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_227.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/65>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "rat: levels of T3 and T4 in the 130 mg resorcinol/kg bw/d 5 days per week group were comparable to the control values. mice: no resorcinol-related, biologically significant changes in clinical chemistry parameters was seen." ;
        ont:clinical_observations   "rats: the final mean body weights and changes in mean body weights of rats receiving resorcinol were similar to those of the controls. tremors were observed in high-dose rats of both sexes. changes in organ weights were recorded in the liver of both sexes and in the adrenal glands of males. absolute and relative liver weights of males dosed with 130 mg/kg bw/d or 260 mg/kg bw/d were statistically significantly increased (p<0.01) compared to the controls.  for females, statistically significant increased absolute liver weights were recorded after doses higher than 32 mg/kg bw/d. the efsa panel noticed that the increases in liver weights in the treated groups were slight, with no marked dose-response relationships, and not accompanied by any changes in clinical chemistry parameters indicative of impaired liver function, or by any histopathological changes. the efsa panel considered therefore that the effect on the liver weight was not biologically significant.  the absolute and relative weights of the adrenal glands in males from all dosed groups were statistically significantly increased (p<0.01) compared to the controls. the efsa panel noted that the absolute adrenal weights were low in the male controls, that no dose-response relationship was apparent, and that the changes in adrenal weights were not accompanied by histopathological findings (ntp, 1992). mice: final body weights of the 2 surviving high-dose male mice were statistically significantly less than controls. final body weights and changes in body weights of all other mice receiving resorcinol were similar to those of the controls. clinical signs of toxicity recorded for the high-dose animals were dyspnoea, prostration, and tremors. these signs appeared within 30 minutes of dosing. statistically significant decreases (p<0.01) were noted in absolute and relative adrenal gland weights in males from all dosed groups. the efsa panel noticed that there was no dose-response relationship for the decreased adrenal weights and that the changes were not accompanied by microscopical findings." ;
        ont:compound                <http://toxin.vub.be/resource/compound/resorcinol> ;
        ont:conclusion              "the efsa panel considered 130 mg resorcinol/kg bw/day as the noael in rats and 225 mg resorcinol/kg bw/d in b6c3f1 mice. the dose causing mortality was less than two-fold greater than this noael. rats:  due to the incorrect dosing of the animals in the 260 mg resorcinol/kg bw/day dose-group the panel concluded that this dose-group should not be used to define the noael." ;
        ont:critical_effect         "mice: clinical signs" ;
        ont:description_pod         "noael mg/kg bw/d  in rats; in mice" ;
        ont:gross_pathology         "in both species  there were no gross lesions attributable to resorcinol administration." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "rat: no differences were observed in haematology or clinical chemistry parameters that could be attributed to the resorcinol administration. few significant differences in various parameters were scattered among the groups, but none were considered biologically significant. mice: no resorcinol-related, biologically significant changes in haematology was seen." ;
        ont:histopathology          "in both species no microscopical lesions attributable to resorcinol administration" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes; yes" ;
        ont:mortality_rate          "rat: all female and 8 male rats from the high-dose group died from resorcinol-related toxicity during the first four weeks of the study. on day 2 of the study, rats from the 260 mg/kg bw/d group were given 520 mg/kg bw/d by mistake. within 5 days, two males and four females in this group died. these deaths were attributed to incorrect dosing because no further deaths occurred among rats receiving the correct dose during the study. mice: in the high-dose group seven mice of each sex died during the first week of the study, another male died during week 4 and another female died during week 12. authors of the study attributed these deaths to resorcinol-related toxicity. one male died in the 112 mg/kg bw group due to improper gavage technique" ;
        ont:point_of_departure      "130; 225" ;
        ont:species_strain          "rat /f344/n; mice/ b6c3f1" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/100>
        a                            ont:Test ;
        ont:additional_info          "test substance: HC Yellow n°4" ;
        ont:blood_serum_biomarkers   "only minor differences was seen in the clinical chemistry values at 13 weeks" ;
        ont:chemical_batch_nr        "S022900186" ;
        ont:clinical_observations    "after 13 weeks, 10 rats per sex per group were killed, blood samples were taken for clinical chemistry and haematology studies and liver, kidneys, gonads, thyroids, brain, pituitary, adrenals, and heart were weighed and microscopically examined. following the 13 weeks, 25 of the remaining females in each group were mated to untreated males in a teratology study. they were killed on day 20 of gestation for foetal examination. 10 of the remaining females in each group were maintained on their respective diets for a total of 26 weeks. the 10 remaining females in groups c and d were kept on their respective diets for a total of 21 weeks and were then placed on the control diet for 5 weeks. 20 of the males per group remaining after the 13 week necropsy were kept on their respective diets for an additional 7 weeks at which time the test diet were replaced by the control diet and the males were mated to 2 virgin untreated females each week for 2 weeks. these females were then evaluated for a dominant lethal mutagenicity effect due to treatment of the males with hc yellow n°4. the 10 remaining males per group were kept on their respective diets for a total of 26 weeks at which time they, along with all remaining animals, were killed and selected organs were weighed (including testis) and a complete set of tissues were taken for possible microscopic examination. during the first 13 weeks of the study, sporadic increases and decreases in weight gain and food consumption occurred in both the males and females. the high level males gained significantly less weight than the controls at the early onset of the study, with the low and mid level males sporadically gaining significantly more weight than the control during the remaining 13 weeks. the high level females gained significantly less weight than the controls during the entire study and the mid level females sporadically less. food consumption by male rats in the high, mid and low dose groups was significantly increased from the control at different time periods during the early weeks of the study. food consumption by females from the high and mid dose groups was sporadically increased or decreased from the control during the study. in the low dose group, female food consumption significantly decreased from the control. " ;
        ont:compound                 <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:concentration            "0, 0.1, 0.3, 1.0" ;
        ont:functional_observations  "body weight gain depression, " ;
        ont:gross_pathology          "no consistent dose related changes were seen in liver and kidney weights. testis weights were unaffected." ;
        ont:guideline                <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel           "non OECD" ;
        ont:haematology              "only minor difference was seen in the haematology at 13 weeks" ;
        ont:histopathology           "no dose-related histomorphologic alterations were noted in any of the tissues examined." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate           "during the first week of the study, one female from the 1% dose group was found dead and was therefore replaced. during the rest of the 13-week study, one female from the control group and one female from the 0.1% dose group died. these deaths were not considered related to the test material." ;
        ont:purity                   "99.65" ;
        ont:species_strain           "rat/sprague-dawley (tac:n(sd)fbr)" ;
        ont:type                     "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/44>
        a                            ont:Test ;
        ont:additional_info          "test substance: zinc omadine ® > 95% active ingredient" ;
        ont:blood_serum_biomarkers   "concerning clinical chemistry data in plasma, there appeared to be no dose-related differences between groups." ;
        ont:chemical_batch_nr        "zinc omadine ® master log # 74-01B10Cu zpt sample 0108244691" ;
        ont:clinical_observations    "animals were not acclimatized to test tubes prior to dosing. therefore some effects might be attributed to the stress produced in the animals. clinical signs observed were wet fur around the muzzle, gasping, respiratory gurgles, swelling around the eyes, hypothermia and intermittent tip-toe walking. " ;
        ont:compound                 <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion               "the loaec was based on histopathological data in tissues of the respiratory tract and non-respiratory tissues" ;
        ont:critical_effect          "histopathological effect in tissues of the respiratory tract and non-respiratory tissues" ;
        ont:description_pod          "loaec mg/m3" ;
        ont:functional_observations  "there was no difference between treated and control animals in fob. grip strength was not affected by dosing." ;
        ont:gross_pathology          "except for lung, there were no differences in organ weights between control and treated animals. lung weights at the 5-day and 21-day sacrifice were increased for all exposure groups except for the 12.0 mg/m3  treated males at day 5 and the 2.0 mg/m3  treated males at day 21." ;
        ont:guideline                <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel           "non OECD" ;
        ont:haematology              "concerning clinical chemistry data in  haematology data, there appeared to be no dose-related differences between groups." ;
        ont:histopathology           "histopathological examination revealed the following compound-related effects: hyperplasia of alveolar marcrophages; inflammation of the nasal mucosa and interstitium around the bronchioles and vessels of the lungs; inflammation of the larynx which appeared ulcerative in a few animals; mucous cell hypertrophy of the nasal and bronchial mucosa; squamous metaplasia of the nasal mucosa, larynx and trachea; and smooth muscle hypertrophy of the alveolar ducts. the severity of these effects increased modestly with increasing dose and is consistent with irritation as a result of exposure to the dust of zpt, a known irritant to mucosal membranes. of non-respiratory tissues, effects in thymus and lymph nodes (lymphoid depletion and the lymph nodes and thymus in some animals) were observed. " ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate           "there was one death in the mid dose and 4 deaths in the high dose group." ;
        ont:physical_form            "aerosols generated from the fine white powder of the substance" ;
        ont:point_of_departure       "2" ;
        ont:purity                   "98.3" ;
        ont:species_strain           "rat/sprague-dawley" ;
        ont:target_organ             "lung, thymus, lymph nodes" ;
        ont:type                     "in vivo" .

<http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane>
        a               ont:Compound ;
        rdfs:label      "decamethylcyclopentasiloxane" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/decamethylcyclopentasiloxane> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/23>
        a                    ont:Test ;
        ont:additional_info  "test substance: 1,4-diamino-anthraquinone " ;
        ont:composition      "hair dye fomrulation" ;
        ont:compound         <http://toxin.vub.be/resource/compound/disperse%20violet%201> ;
        ont:concentration    "5" ;
        ont:conclusion       "under the experimental conditions adopted, no adverse effects were observed with the tested preparation. " ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "mouse/ hairless" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/dossier/phenylene%20bis-diphenyltriazine>
        a              ont:Report ;
        rdfs:label     "phenylene bis-diphenyltriazine" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/66> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fsites%2Fhealth%2Ffiles%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_215.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/94>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "the authors mentioned several findings considered incidental or of doubtful significance: trend towards decrease in male serum cholesterol with increasing doses." ;
        ont:clinical_observations   "no statistically significant adverse effects. a dose-dependent decrease in body weight gain and  at exposure termination, no significant differences between high-dose and control groups were reported. however, the authors mentioned several findings considered incidental or of doubtful significance: trend towards a decrease in body weight gains with increasing doses (body weights showed no significant differences)" ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:conclusion              "the noael for dietary exposure in dogs in this study is 250 mg/kg bw/day." ;
        ont:description_pod         "noael mg/kg bw/day" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "an increase in platelet count and megakaryocytes within a normal range were observed. the authors mentioned several findings considered incidental or of doubtful significance: trend towards a slight increase in platelet count with increased megakaryocytes" ;
        ont:point_of_departure      "250" ;
        ont:purity                  "99.9" ;
        ont:species_strain          "dog/beagle" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/compound/2%2C6-dihydroxyethylaminotoluene>
        a               ont:Compound ;
        rdfs:label      "2,6-dihydroxyethylaminotoluene" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/2%2C6-dihydroxyethylaminotoluene> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/129>
        a                          ont:Test ;
        ont:additional_info        "test substance: HC Yellow n2" ;
        ont:clinical_observations  "no adverse effect on average body weight and on survival rate was observed.chronic inflammation of the skin was observed in the control and treated mice." ;
        ont:composition            "hair dye formulation" ;
        ont:compound               <http://toxin.vub.be/resource/compound/HC%20Yellow%20n°%202> ;
        ont:concentration          "0.5" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "no observations in the haematological values indicative of a toxic effect due to the hair dye treatments" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:physical_form          "liquid" ;
        ont:species_strain         "mouse/Eppley Swiss" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "no observations in the urinary values indicated a toxic effect due to the hair dye" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/73>
        a                           ont:Test ;
        ont:additional_info         "test substance : bmhca" ;
        ont:blood_serum_biomarkers  "bmhca induced anaemia, increased values of urea and creatinine" ;
        ont:clinical_observations   "bmhca led to decreased body weight gain including severe body weight loss, organ weight changes in the liver and the male-reproductive organs (testes, prostate)" ;
        ont:compound                <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:critical_effect         "organ weights of testes and prostate were decreased and histomorphological correlates were noted; altered sperm quality and reduced sperm motility were noted." ;
        ont:gross_pathology         "organ weight changes in the liver and the male-reproductive organs (testes, prostate)." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "dog / beagle" ;
        ont:target_organ            "male reproductive organs:" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/108>
        a                          ont:Test ;
        ont:additional_info        "test substance: SOPP" ;
        ont:clinical_observations  "investigation of the urinary bladder by LM and SEM at several time points did not reveal any effects." ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:species_strain         "mouse/b6c3f1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/52>
        a                          ont:Test ;
        ont:additional_info        "test substance: NTA.H2O & H3NTA" ;
        ont:clinical_observations  "all doses of nta.H2O reduced growth. body weight reduction was seen at 525 mg/kg bw/day and above." ;
        ont:compound               <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration          "0, 0.5, 0.75, 1.5, 2 & 0, 0.5, 0.75, 1.5" ;
        ont:conclusion             "related to the limited parameters under investigation, no noael was estimated for both nta forms. 350 mg/kg bw/day of  NTA.H2O or H3NTA was considered as loael." ;
        ont:description_pod        "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure     "92" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "the effects on growth, urine pH and urine volume were measured. the urines from the animals consuming both forms of 525 mg/kg bw/day nta contain insoluble material and haematuria was observed in the urines of rats at 1050 mg/kg bw/day nta.H2O. x-ray analyses showed that the insoluble material contained crystalline calcium chelate of nta (CaNaNTA, not quantified). all doses of nta.H2O increased urine pH above the controls. urine volume was reduced at 350 mg/kg bw/day but higher doses increased the volume dose-dependently. lower urine volume was measured at 350 mg/kg bw/day H3NTA and higher, but decrease did not show dose-relationship. decreased urine pH-values was seen at 525 mg/kg bw/day and above. " .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/31>
        a                          ont:Test ;
        ont:clinical_observations  "no significant effects have been noted other than the hind-limb weakness or paralysis which occurred in rats and rabbits within 8 to 14 days when zpt was administered in the diet at levels from 165 ppm to 330 ppm (8-16 mg/kg/day). doses greater than 330 ppm required longer periods of administration before paralysis occurred." ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion             " with respect to paralysis, a noel of 0.5 mg/kg/day (500 μg/kg/d) has been determined in two year feeding studies in rats. at this dose no toxic effects were observed over the two-year study period. " ;
        ont:critical_effect        "paralysis" ;
        ont:description_pod        "noel  mg/kg/d (500µg/kg/d)" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "at levels of 1000 ppm or greater, the animals usually died without developing paralysis" ;
        ont:point_of_departure     "0.5" ;
        ont:species_strain         "rat; rabbit" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/10>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "there were slight increases in liver enzyme values including alt, ast, and gamma-glutamyltransferase" ;
        ont:clinical_observations   "there were 6 dropouts (5 triclosan and 1 placebo) due to adverse effects (skin reactions - 3 subjects including 1 placebo subject; increase in liver enzymes - 2 subjects; and, antrum gastritis - 1 subject). these findings were not considered to be attributable to triclosan, as they are not uncommon in pharmacological studies" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion              "based on vital signs, ecg, lung function, neurological examination and most laboratory parameters, triclosan was considered to be well-tolerated" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/compound/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride>
        a               ont:Compound ;
        rdfs:label      "alkyl (C16, C18, C22) trimethylammonium chloride" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/alkyl%20%28C16%2C%20C18%2C%20C22%29%20trimethylammonium%20chloride> .

<http://toxin.vub.be/resource/dossier/Acid%20black%201>
        a              ont:Report ;
        rdfs:label     "Acid black 1" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/132> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_018.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/137>
        a                          ont:Test ;
        ont:additional_info        "test substance: d5" ;
        ont:clinical_observations  "neither treatment-related deaths, overt signs of toxicity, nor changes in behaviour were observed in any of the groups. treatment-related increases in liver weights (absolute and relative weights) were observed at 100 (31%), 400 (36%) and 1600 mg/kg bw/day (48%) in female rats. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/decamethylcyclopentasiloxane> ;
        ont:conclusion             "a LOAEL and a NOAEL for increased liver weight of 100 and 25 mg/kg bw/day, respectively, were reported for female rats. no significant changes were observed at gross pathological examination." ;
        ont:critical_effect        "increase liver wight" ;
        ont:description_pod        "mg/kg bw/d LOAEL & NOAEL" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:point_of_departure     "100 & 25" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/81>
        a                    ont:Test ;
        ont:additional_info  "test substance: p-aminophenol$" ;
        ont:compound         <http://toxin.vub.be/resource/compound/p-aminophenol> ;
        ont:conclusion       "no death, clinical signs, or histopathological findings could be attributed to compound administration" ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain   "rat/wistar" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/116>
        a                          ont:Test ;
        ont:additional_info        "test substance: Dowicide 1" ;
        ont:chemical_batch_nr      "MM01040" ;
        ont:clinical_observations  "body weights were significantly (p < 0.05) decreased at the two highest dose levels, increased water intake was observed from 92 mg/kg bw/d.   " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration          "0, 0.65, 1.3, 2.6 " ;
        ont:conclusion             "based on the induction of renal tubular epithelium degeneration, spleen atrophy, increased water intake, and increased relative liver weight, occurring at each concentration tested, a NOAEL cannot be derived. 92 mg/kg/day can be considered as LOAEL. " ;
        ont:gross_pathology        "OPP affected kidneys, urinary bladder, liver and spleen. the main effect in the spleen was atrophy (mainly of very slight grade), which was observed in each of the exposed groups. in the liver, although only OPP-treated groups had tumours (type not stated), the tumour incidences did not represent a dose response: the respective incidences at 0, 0.65, 1.3 and 2.6 % OPP were 0%, 5%, 10%, and 5%. in urinary bladder, increases (p<0.05) in the absolute weight occurred at 198 mg/kg bw/d (37 %) and the relative weights at 198 mg/kg bw/d (70 %) and 447 mg/kg bw/d (59 %). reduced (p<0.05) absolute kidney weights occurred in each of the OPP-treated groups (7-24 %), but the dose-response seemed consistent with the general body weight reductions noted in these groups (12-43 %). " ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "OPP induced nonneoplastic lesions in the kidneys (p<0.05 when all severity grades are combined) at the low, mid, and high doses. in addition to the increased incidence, the lesion severity (e.g., tubular epithelium degeneration) also appeared to increase with dose." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "one death occurred at the highest dose level." ;
        ont:species_strain         "mouse/ Crj:B6C3F1" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/8>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "standard clinical biochemistry results showed some statistically significant changes periodically (compared to baseline values), but no pattern to the changes. some significant correlations were found between parameters and triclosan blood levels, but these were inconsistent over the course of the study in terms of time or sex of subject." ;
        ont:composition             "toothpaste containing 0.2% of triclosan and 0.5% zinc citrate" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:concentration           "0.2" ;
        ont:conclusion              "these changes were not attributed to triclosan toothpaste use." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "standard haematology results showed some statistically significant changes periodically (compared to baseline values), but no pattern to the changes. some significant correlations were found between parameters and triclosan blood levels, but these were inconsistent over the course of the study in terms of time or sex of subject." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/60>
        a                       ont:Test ;
        ont:additional_info     "test substance: sodium perborate tetrahydrate, 215 mg/ml" ;
        ont:compound            <http://toxin.vub.be/resource/compound/sodium%20perborate%20%28tetrahydrate%29> ;
        ont:concentration       "21.5" ;
        ont:conclusion          "in conclusion the noel for these endpoints is below the dose of 1000 mg/kg bw/d tested." ;
        ont:description_pod     "loael mg sodium perborate tetrahydrate/kg bw/d (70 mg boron/kg bw/d)" ;
        ont:gross_pathology     "the spleen size was reduced." ;
        ont:guideline           <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel      "non OECD" ;
        ont:haematology         "after application of 1000 mg/kg bw/d at the end of the study red blood cell count, haemoglobin, haematocrit and number of lymphocytes was statistically significantly decreased, the number of platelets was statistically significantly increased." ;
        ont:histopathology      "acanthosis and hyperkeratosis in the forestomach and hyperplasia of the fundic mucosa were observed after application of 1000 mg/kg bw/d via gavage. the spleenic parenchyma was reduced." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure  "1000" ;
        ont:species_strain      "rats" ;
        ont:target_organ        "stomach, haematological system and possibly the testes" ;
        ont:type                "in vivo" .

<http://toxin.vub.be/resource/dossier/p-aminophenol>
        a              ont:Report ;
        rdfs:label     "p-aminophenol" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/85> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/80> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/86> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/83> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/84> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/87> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/81> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/82> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_078.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/39>
        a                    ont:Test ;
        ont:additional_info  "test substance: zpt" ;
        ont:compound         <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:concentration    "0.08, 0.4, 2.0" ;
        ont:conclusion       "none of the treatments produced local or systemic effects after a total of 30 applications (six weeks). the study was terminated at this point." ;
        ont:gross_pathology  "four animals, two group housed and two single-housed, treated with the mixture containing 2% zpt were necropsied after six weeks of treatment, and no gross abnormalities were observed." ;
        ont:guideline        <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel   "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:pH_adjustment    "test materials were zpt at 0.08, 0.4 and 2.0% in a 1 % surfactant (triethanolamine lauryl sulfate)/ 0.5% thickener (methocel) aqueous slurry, these levels correspond to 0.28, 1.4, and 7.0 mg/kg/day" ;
        ont:species_strain   "mouse" ;
        ont:type             "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/18>
        a                      ont:Test ;
        ont:chemical_batch_nr  "fda certified colour was used." ;
        ont:composition        "test substance dissolved in water" ;
        ont:compound           <http://toxin.vub.be/resource/compound/acid%20orange%207> ;
        ont:concentration      "1" ;
        ont:conclusion         "the authors conclude that no adverse reactions or pathological changes were observed following weekly dermal applications of d&c orange 4." ;
        ont:guideline          <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel     "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain     "mouse/swiss webster" ;
        ont:type               "in vivo" .

<http://toxin.vub.be/resource/compound/methylimidazoliumpropyl%20p-phenylenediamine%20HCl>
        a               ont:Compound ;
        rdfs:label      "methylimidazoliumpropyl p-phenylenediamine HCl" ;
        ont:compoundOf  <http://toxin.vub.be/resource/dossier/methylimidazoliumpropyl%20p-phenylenediamine%20HCl> .

<http://toxin.vub.be/resource/dossier/triclosan>
        a              ont:Report ;
        rdfs:label     "triclosan" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/133> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/10> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/6> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/5> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/135> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/134> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/8> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/4> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/7> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/3> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/9> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fph_risk%2Fcommittees%2F04_sccp%2Fdocs%2Fsccp_o_166.pdf> .

<http://toxin.vub.be/resource/dossier/hc%20yellow%20n°%204>
        a              ont:Report ;
        rdfs:label     "hc yellow n° 4" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/98> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/100> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/99> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/96> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/97> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/101> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_008.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/89>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "several serum parameters were mildly affected: decreases in glucose (≥ 1234 mg/kg bw/day) and alkaline phosphatase activity (alp) (2019 mg/kg bw/day) in males; minimal decreases in total proteins and albumin and mild increase in cholesterol in males and females at the highest dose." ;
        ont:clinical_observations   "lower body weights and body weight gains were noted at ≥ 1234 mg/kg bw/day in males and at 2268 mg/kg bw/day in females. in males, the body weight gains over test days 0-28 were by 40 and 72 % less than controls at 1234 and 2019 mg/kg bw/day, respectively. in females, it was reduced by 52 % at the high dose. these decreases were correlated with lower food consumption. slight, but non-significant lower cumulative weight gain was observed in males at 429 mg/kg bw/day and in females at 1548 mg/kg bw/day  . " ;
        ont:compound                <http://toxin.vub.be/resource/compound/n-methyl-2-pyrrolidone%20%28NMP%29> ;
        ont:conclusion              "the authors concluded that, rather than specific organ toxicity, a general systemic response seemed to occur. " ;
        ont:critical_effect         "general toxicity" ;
        ont:description_pod         "noaelmg/kg bw/day (6000 ppm) for males; mg/kg bw/day (18000 ppm) for females." ;
        ont:gross_pathology         "in males the weight of testes was also altered (not detailed)" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "moderate leucopoenia was observed at the highest dose in males and females. It was judged secondary to nutritional and body weight effects." ;
        ont:histopathology          "histopathological alterations (hypo-cellular bone marrow in males and females, testicular degeneration and atrophy in males, and thymus atrophy in females) was observed at the highest dose in males and females. it was judged secondary to nutritional and body weight effects. centrilobular hepatocellular hypertrophy occurred in males and females at the two highest doses (0/5 males or females in the control and the two lowest doses; 5/5 and 4/5 males at 1234 and 2019 mg/kg bw/day, respectively; 3/5 and 5/5 females at 1548 and 2268 mg/kg bw/day, respectively). it was considered an adaptative response. males showed degeneration and/or atrophy of the testicular seminiferous tubules (0/5, 0/5, 0/5, 1/5, and 5/5, at 0, 149, 429, 1234, and 2019 mg/kg bw/day, respectively)." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure      "429; 1548" ;
        ont:purity                  "99.9" ;
        ont:species_strain          "rat/orl:cd.br" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/124>
        a                           ont:Test ;
        ont:additional_info         "test substance: 1-Hydroxy-2aminobenzene" ;
        ont:blood_serum_biomarkers  "alkaline phosphatase in blood biochemistry analysis revealed to be different between the treated and the control group" ;
        ont:composition             "solution in vehicle" ;
        ont:compound                <http://toxin.vub.be/resource/compound/o-aminophenol> ;
        ont:concentration           "1" ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:histopathology          "Histopathological examination showed broncho-pulmonary injuries which did not permit to affirm the toxicity of the substance." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "rat/sprague-dawley" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/68>
        a                          ont:Test ;
        ont:additional_info        "test substance: bmhca, lysmerylic acid" ;
        ont:clinical_observations  "rat: no clinical signs were observed. body weight gains were found to be decreased by 25% and 20% below controls after application of bmhca for 14 days. mouse: no clinical signs were observed. bmhca led to a reduction in the ratio of normal to abnormal sperm in animals after exposure of 3 and 4 days." ;
        ont:compound               <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:gross_pathology        "rat: slight to severe testicular atrophy with an incidence of 2/5 animals for bmhca after a single application, and in all animals after longer application periods was observed. Mouse: macroscopic evaluation of the testes revealed no pathological changes" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "mouse: microscopic evaluation of the testes revealed no pathological changes." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rat /wistar;  mouse /c57bl" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/103>
        a                           ont:Test ;
        ont:additional_info         "test substance: SOPP" ;
        ont:blood_serum_biomarkers  "no changes were noted in biochemical investigations of plasma samples." ;
        ont:clinical_observations   "body weight gain dose-dependently decreased at 1.25 and 2.5%." ;
        ont:compound                <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:concentration           "0, 0.625, 1.25, 2.5" ;
        ont:critical_effect         "Decrease of urinary pH observed; acidification could be due to nephritis" ;
        ont:gross_pathology         "the relative weight of the urinary bladder was dose-dependently increased (nearly by about 50% at the highest concentration)." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "red blood cell count and the amount of haemoglobin were decreased at 2.5%." ;
        ont:species_strain          "rat/f344" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "the number of rats with acidic urinary pH values was increased at 1.25 and 2.5%, urinary protein levels were decreased at 2.5%." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/47>
        a                           ont:Test ;
        ont:additional_info         "test substance: sodium omadine TM" ;
        ont:blood_serum_biomarkers  "concerning clinical chemistry and urinalysis, there were no toxicologically relevant treatment-related findings." ;
        ont:chemical_batch_nr       "8508-p-166h" ;
        ont:clinical_observations   "clinical signs observed were hindlimb muscle atrophy in high dose animals. body weight was reduced in high dose females." ;
        ont:composition             "aqueous solution of the test substance" ;
        ont:compound                <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion              "under the conditions of this study, NaPT was not carcinogenic to rats. based on the nonneoplastic findings observed, a noael of 0.5 mg/kg bw/d can be derived from this study. " ;
        ont:critical_effect         "hindlimb muscle atrophy, body weight depression, haematology alteration, degeneration of muscle fibres, degeneration of spinal cord and sciatic nerve fibres and peripheral retinal atrophy" ;
        ont:description_pod         "noael mg/kg bw/day" ;
        ont:gross_pathology         "relative lung weights were increased in mid and high dose males." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "haematology revealed reductions in red blood cell count and haematocrit in high dose females." ;
        ont:histopathology          "non-neoplastic findings observed at the high dose were degeneration of muscle fibres, degeneration of spinal cord and sciatic nerve fibres and peripheral retinal atrophy at the high dose. the effects were also observed to a lesser degree at 1.5 mg/kg bw/d. the incidence of neoplastic findings was not influenced by substance treatment" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "121 males and 90 females died or were killed in extremis, deaths were considered not related to treatment by the authors" ;
        ont:point_of_departure      "0.5" ;
        ont:purity                  "41.2" ;
        ont:species_strain          "rat / crl:cd-1 (icr) br (vaf plus)" ;
        ont:target_organ            "lung, haematopoietic system, muscles, nerves" ;
        ont:type                    "in vivo" ;
        ont:urinalysis              "concerning clinical chemistry and urinalysis, there were no toxicologically relevant treatment-related findings." .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/26>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "hepatotoxicity, changes in lipid metabolism and in bone density, and teratogenicity " ;
        ont:composition             "retinol and retinyl esters" ;
        ont:compound                <http://toxin.vub.be/resource/compound/vitamin%20a> ;
        ont:conclusion              "cases of hepatotoxicity have not been reported below 7500 mg retinol equivalence/day, and it can be hypothesised that this value might be the upper threshold of the storage capabilities of the liver." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate          "death of one patient due to progressive liver failure, cirrhosis" ;
        ont:species_strain          "human" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/dossier/decamethylcyclopentasiloxane>
        a              ont:Report ;
        rdfs:label     "decamethylcyclopentasiloxane" ;
        ont:contains   <http://toxin.vub.be/resource/test/repeated-dose-toxicity/142> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/143> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/138> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/140> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/139> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/141> , <http://toxin.vub.be/resource/test/repeated-dose-toxicity/137> ;
        ont:guideline  <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:seeAlso    <http://toxin.vub.be/resource/pdfLink/https%3A%2F%2Fec.europa.eu%2Fhealth%2Fscientific_committees%2Fconsumer_safety%2Fdocs%2Fsccs_o_174.pdf> .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/97>
        a                          ont:Test ;
        ont:additional_info        "test substance: HC Yellow n°4" ;
        ont:chemical_batch_nr      "CN22900186" ;
        ont:clinical_observations  "no pharmacologic and/or toxicological effects were reported except discoloured fur and urine. the mean body weights were significantly decreased in males treated at the doses of 0.5% at the week 1, 1.0% during weeks 1-3, and 1.25% and 1.50% during weeks 1-4. the mean body weights were significantly decreased in females treated at all doses at week 4. mean terminal body weight were significantly decreased in the males treated at the doses of 1.0%, 1.25% and 1.50% and in the females treated at the doses of 1.25% and 1.50%. " ;
        ont:composition            "HC Yellow n° 4 in diet (purina certified chow 5002)" ;
        ont:compound               <http://toxin.vub.be/resource/compound/hc%20yellow%20n°%204> ;
        ont:concentration          "0, 0.5, 1.0, 1.25, 1.5" ;
        ont:conclusion             "based on the results of this study, dose levels of 1%-1.25% of HC Yellow n°4 were proposed for the combined subchronic feeding study." ;
        ont:gross_pathology        "no noteworthy findings were observed at the terminal necropsy. no significant difference was observed in the absolute liver weight of the male rats but a significant increase in the relative liver weight in all tested groups for the male rats was reported. there was a significant decrease in both absolute and relative liver weights for the female rats treated at the dose of 0.5% and 1.0%. a significant increase in the relative liver weight in the female rats treated at the dose of 1.5% was observed. a significant decrease in the absolute kidney weight in the male rats treated at the dose of 1.25% and 1.50% and in all treated female rats was observed. no significant differences were observed in the relative kidney weights." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/132>
        a                          ont:Test ;
        ont:additional_info        "test substance: Acid Black 1" ;
        ont:chemical_batch_nr      "9405" ;
        ont:clinical_observations  "clinical observations included dark faeces at all doses; orange urine and sedation at the high and mid doses; and piloerection, salivation, half closed lids and emaciation at the high dose. body weight, body weight gain and food consumption decreased only in the high dose group." ;
        ont:compound               <http://toxin.vub.be/resource/compound/Acid%20black%201> ;
        ont:conclusion             "based on these results, the highest dose for the 90 day study was proposed to be 180 mg/kg/bw." ;
        ont:gross_pathology        " the spleen in animals from both the mid dose and high dose groups showed a dose related increase in weight. in the high dose males there was a significant increase of the relative organ/body weight ratio of the liver. in addition animals in the high dose groups showed black discolouration of the intestine, liver, kidney, spleen, stomach, urinary bladder and uterus." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:homogeneity_stability  "doses were prepared daily. homogeneity and stability of acid black 1 in bi-distilled water containing 1% cmc was performed." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "at the high dose, two males (days 5 and 9) and four females (days 2, 5 12 and 15) were found dead. " ;
        ont:purity                 "94,8" ;
        ont:species_strain         "rat/Wistar Hanlbm: WIST (SPF)" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/76>
        a                           ont:Test ;
        ont:additional_info         "test substance: bmhca" ;
        ont:blood_serum_biomarkers  "treatment-related effects again included the decrease of plasma cholesterol, cholinesterase and acetylcholinesterase levels. " ;
        ont:compound                <http://toxin.vub.be/resource/compound/butylphenyl%20methylpropional%20%28p-bmhca%29> ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:purity                  "97.4" ;
        ont:species_strain          "rats /albino, fü spf" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/111>
        a                          ont:Test ;
        ont:additional_info        "test substance: OPP" ;
        ont:clinical_observations  "in week 4, 8, and 12 five rats per group were examined by LM and SEM. the bladders of OPP-treated rats presented abnormal picture at all times of examination. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/o-phenylphenol%2C%20sodium%20o-phenylphenate%20and%20potassium%20o-phenylphenate> ;
        ont:conclusion             "study demonstrates that  SOPP is a more potent bladder toxicant in rat than OPP." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:purity                 "98" ;
        ont:species_strain         "rat/f344" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/3>
        a                           ont:Test ;
        ont:blood_serum_biomarkers  "there was no treatment-related biochemical changes" ;
        ont:clinical_observations   "study showed no toxicity except for dermal irritation at the highest dose tested. upper respiratory disease during the study up to day 25. diarrhoea in all animals was not attributed to the test substance. dermal irritation (dermatitis) was observed at the high dose and was dose-dependent.." ;
        ont:composition             "12.5% triclosan added to 50% corn-starch vehicle" ;
        ont:compound                <http://toxin.vub.be/resource/compound/triclosan> ;
        ont:conclusion              "test substance was reported to show “little toxic effect” aside from dermal irritation (pathology data not reported)." ;
        ont:guideline               <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel          "non OECD" ;
        ont:haematology             "there was no treatment-related  haematological changes" ;
        ont:histopathology          "microscopic examination revealed no histomorphology changes in the skin." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:species_strain          "dog/Beagle weanling" ;
        ont:type                    "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/55>
        a                          ont:Test ;
        ont:additional_info        "test substance: NTA.H2O / H3NTA" ;
        ont:clinical_observations  "in comparison to the control group, the two forms of nta resulted in comparable decreases in growth rate during the exposure phase of the study, these animals gained more weight during the recovery phase." ;
        ont:compound               <http://toxin.vub.be/resource/compound/trisodium%20nitrilotriacetate> ;
        ont:concentration          "2; 1.5" ;
        ont:conclusion             "nta treatment was related to vacuolation, simple and nodular hyperplasia of the vacuolated cell type and the basophilic cell type in the proximal convoluted tubules, and transitional cell erosion, ulceration, hyperplasia and dysplasia associated with hydronephrosis in the renal pelvis. nodular hyperplasias and urothelium lesions were shown to be reversible within this model, whereas simple basophilic hyperplasia of tubules and pelvic hydronephosis persisted. vacuolation and basophilia of tubular cells with or without increased cell size is known to be a response to tubular injury. lesions observed at the pelvis area are also characteristic for degenerative and regenerative response of urothelial cells. the authors discussed the higher incidence of basophilic cell hyperplasia being nonspecific and related to spontaneous age-related nephrosis. they were considered to be exacerbated by the ingestion of high doses of nta. although no data were reported for the acclimatisation period, it is assumed that rats were about 8 ± 2 weeks at the start of the study. at the end of study, rats were about 15 ± 2 weeks old. therefore the role of spontaneous chronic progressive nephropathy of the old rat could not be clarified at this relatively young age and by the low number of animals (males only) examined. with respect to the renal damage, no noael was established  the loaels were 2% NTA.H2O (appr. 1309 mg/kg bw/d) and 1.5% H3NTA (appr. 1050 mg/kg bw/d)." ;
        ont:description_pod        "noael for non-cancer endpoints, mg/kg bw/d" ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:histopathology         "both forms induced vacuolation and hyperplasia often composed of vacuolated cells in the epithelium of the proximal convoluted tubules. these effects were noted in all of the exposed animals although the extent of damage varied. tubular vacuolation was evident in each animal of the NTA groups, but was absent in the control groups and in the recovery groups indicating complete recovery. the total incidence of (simple) basophilic cell hyperplasia was greater in the nta groups than in control groups after treatment and recovery period. tubules that had a diameter more than twice of that of a normal proximal convoluted tubule were classified as tubular hyperplastic nodules of the vacuolated cell type. nodular basophilic cell hyperplasia was only seen in treated groups and was absent in the control and recovery groups. pelvic epithelial and subepithelial inflammation and fibrosis were observed in the groups given either form of nta for 49 days. mild to severe hyperplasia of the transitional epithelium (TE) in the renal pelvis occurred in 4/7 animals given diets containing NTA.H2O and moderate TE hyperplasia was observed in 1/8 rats given H3NTA in the diet. animals with TE hyperplasia also exhibited pelvic dilation and TE erosion, ulceration and haemorrhage. TE dysplasia, intracytoplasmic globules, and mitotic figures were also noted. tissues from recovery animals showed no abnormal cellular morphology in the pelvic urothelium in the presence of persisting hydronephrosis." ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "no" ;
        ont:point_of_departure     "92" ;
        ont:species_strain         "rat/sprague-dawley" ;
        ont:type                   "in vivo" .

<http://toxin.vub.be/resource/test/repeated-dose-toxicity/34>
        a                          ont:Test ;
        ont:additional_info        "test substance: zinc omadine ® powder" ;
        ont:chemical_batch_nr      "9204084481" ;
        ont:clinical_observations  "decreased activity, decreased appetite, sporadic vomiting and diarrhea. these signs resolved during the recovery period. no abnormal clinical signs were observed in the lower dose groups. decreased body weights were noted in four males and two females of the highest dose. " ;
        ont:compound               <http://toxin.vub.be/resource/compound/zinc%20pyrithione> ;
        ont:conclusion             "the noael calculated based on decreased lymphocyte counts in male animals observed at 11 mg/kg bw/d" ;
        ont:critical_effect        "decreased lymphocyte counts" ;
        ont:description_pod        "noael mg/kg/d" ;
        ont:gross_pathology        "on gross pathologic examination (apart from the female animal that died on day 10) no test-article related abnormalities were found. the relative organ weights of the adrenal glands and the liver of the high-dosed females were increased. 3 high dose males also had increased relative liver weights. no significant organ weight changes were observed at the lower doses." ;
        ont:guideline              <http://toxin.vub.be/resource/guideline/non%20OECD> ;
        ont:guidelineLabel         "non OECD" ;
        ont:haematology            "in the haematologic examination, a decrease in erythrocyte count, haematocrit, haemoglobin concentration and mchc as well as an increase in mcv were observed in the highest dose group in week 4; the effects resolved during the recovery period. in the two highest dose groups, a decrease in lymphocytes and a decrease in stab. form neutrophilic leucocytes were observed." ;
        ont:histopathology         "on histopathologic examination, no abnormalities were observed in the surviving animals. " ;
        ont:homogeneity_stability  "stability statement: it was confirmed by the sponsor that the test article would be stable for 1 year at room temperature" ;
        ont:moribund_or_dead_animals_prior_to_study_termination
                "yes" ;
        ont:mortality_rate         "one female at the highest dose group died on day 10" ;
        ont:physical_form          "solid" ;
        ont:point_of_departure     "5.5" ;
        ont:purity                 "96.3" ;
        ont:species_strain         "monkey/ cynomolgus" ;
        ont:target_organ           "haematopoietic system" ;
        ont:type                   "in vivo" ;
        ont:urinalysis             "urinalysis revealed an increase in ketone bodies in four males and four females of the highest dose group: pH was reduced in two males." .
